| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.701 | 0.002 | 0.701 | Nav1.1 sodium channel blocker | 0.53 0.003 DBMET01197 0.626 0.003 DBMET01198 0.241 0.013 DBMET01199 | ||
| 0.698 | 0.006 | 0.703 | Vasodilator, peripheral | 0.59 0.017 DBMET01197 0.703 0.006 DBMET01198 0.251 0.126 DBMET01199 | DBMET01198 | |
| 0.671 | 0.016 | 0.748 | Analgesic | 0.748 0.009 DBMET01197 0.601 0.027 DBMET01198 0.42 0.076 DBMET01199 | DBMET01197 | |
| 0.532 | 0.003 | 0.627 | Ca(v)2.2 blocker | 0.627 0.003 DBMET01197 0.402 0.004 DBMET01198 | DBMET01197 | |
| 0.521 | 0.004 | 0.521 | Nav1.3 sodium channel blocker | 0.362 0.005 DBMET01197 0.405 0.005 DBMET01198 0.139 0.056 DBMET01199 | ||
| 0.533 | 0.023 | 0.533 | Thioredoxin glutathione reductase inhibitor | 0.455 0.039 DBMET01197 0.483 0.032 DBMET01198 | ||
| 0.499 | 0.004 | 0.499 | Calcium channel blocker | 0.329 0.008 DBMET01197 0.353 0.006 DBMET01198 0.133 0.074 DBMET01199 | ||
| 0.489 | 0.004 | 0.489 | Calcium channel (voltage-sensitive) blocker | 0.281 0.008 DBMET01197 0.303 0.006 DBMET01198 0.108 0.073 DBMET01199 | ||
| 0.473 | 0.012 | 0.473 | Sigma receptor agonist | 0.441 0.016 DBMET01198 | ||
| 0.461 | 0.003 | 0.461 | Calcium antagonist | 0.295 0.005 DBMET01197 0.309 0.004 DBMET01198 0.156 0.021 DBMET01199 | ||
| 0.48 | 0.026 | 0.514 | Spasmolytic | 0.321 0.062 DBMET01197 0.514 0.021 DBMET01198 0.188 0.13 DBMET01199 | DBMET01198 | |
| 0.441 | 0.004 | 0.441 | Nav1.6 sodium channel blocker | 0.382 0.004 DBMET01197 0.365 0.005 DBMET01198 0.173 0.033 DBMET01199 | ||
| 0.436 | 0.003 | 0.436 | Calcium channel N-type blocker | 0.277 0.006 DBMET01197 0.299 0.005 DBMET01198 0.116 0.069 DBMET01199 | ||
| 0.41 | 0.006 | 0.41 | Nav1.2 sodium channel blocker | 0.369 0.009 DBMET01197 0.339 0.011 DBMET01198 0.119 0.084 DBMET01199 | ||
| 0.409 | 0.022 | 0.409 | Vasodilator | 0.324 0.041 DBMET01197 0.404 0.022 DBMET01198 | ||
| 0.368 | 0.005 | 0.368 | Alpha 2c adrenoreceptor antagonist | 0.241 0.011 DBMET01197 0.313 0.006 DBMET01198 | ||
| 0.353 | 0.011 | 0.412 | 5 Hydroxytryptamine 2B antagonist | 0.412 0.008 DBMET01197 0.239 0.02 DBMET01198 0.148 0.042 DBMET01199 | DBMET01197 | |
| 0.34 | 0.007 | 0.34 | Alpha 2b adrenoreceptor antagonist | 0.293 0.01 DBMET01197 0.279 0.011 DBMET01198 | ||
| 0.322 | 0.005 | 0.335 | Analgesic, opioid | 0.267 0.006 DBMET01197 0.335 0.005 DBMET01198 | DBMET01198 | |
| 0.32 | 0.005 | 0.32 | Histamine H1 receptor antagonist | 0.255 0.009 DBMET01197 0.198 0.015 DBMET01198 0.083 0.055 DBMET01199 | ||
| 0.362 | 0.049 | 0.371 | Vasodilator, coronary | 0.346 0.057 DBMET01197 0.371 0.046 DBMET01198 0.339 0.061 DBMET01199 | DBMET01198 | |
| 0.39 | 0.081 | 0.447 | Histamine release inhibitor | 0.374 0.089 DBMET01197 0.447 0.051 DBMET01198 0.242 0.161 DBMET01199 | DBMET01198 | |
| 0.299 | 0.004 | 0.299 | Calcium channel L-type blocker | 0.162 0.009 DBMET01197 0.206 0.005 DBMET01198 0.089 0.031 DBMET01199 | ||
| 0.286 | 0.004 | 0.286 | Dopamine uptake inhibitor | 0.204 0.006 DBMET01197 0.207 0.006 DBMET01198 0.094 0.02 DBMET01199 | ||
| 0.315 | 0.037 | 0.315 | Anticonvulsant | 0.265 0.051 DBMET01197 0.176 0.102 DBMET01198 0.256 0.055 DBMET01199 | ||
| 0.293 | 0.015 | 0.296 | Antipruritic | 0.296 0.015 DBMET01197 0.286 0.017 DBMET01198 0.157 0.086 DBMET01199 | DBMET01197 | |
| 0.297 | 0.02 | 0.297 | Neuropeptide Y2 antagonist | 0.28 0.03 DBMET01197 0.294 0.021 DBMET01198 0.199 0.12 DBMET01199 | ||
| 0.29 | 0.02 | 0.362 | Lipid peroxidase inhibitor | 0.175 0.053 DBMET01197 0.362 0.012 DBMET01198 | DBMET01198 | |
| 0.266 | 0.004 | 0.266 | Calcium channel T-type blocker | 0.213 0.004 DBMET01197 0.157 0.006 DBMET01198 0.057 0.043 DBMET01199 | ||
| 0.379 | 0.121 | 0.504 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.47 0.049 DBMET01197 0.504 0.032 DBMET01199 | DBMET01199 | |
| 0.277 | 0.021 | 0.472 | Phospholipase C inhibitor | 0.472 0.007 DBMET01197 0.387 0.011 DBMET01198 0.171 0.071 DBMET01199 | DBMET01197 | |
| 0.265 | 0.01 | 0.271 | ATPase inhibitor | 0.201 0.036 DBMET01197 0.271 0.009 DBMET01198 0.243 0.015 DBMET01199 | DBMET01198 | |
| 0.26 | 0.007 | 0.26 | Dopamine D3 antagonist | 0.127 0.019 DBMET01197 0.21 0.01 DBMET01198 | ||
| 0.262 | 0.02 | 0.362 | 5 Hydroxytryptamine 2 antagonist | 0.362 0.012 DBMET01197 0.162 0.04 DBMET01198 0.154 0.043 DBMET01199 | DBMET01197 | |
| 0.263 | 0.028 | 0.284 | Insulin sensitizer | 0.19 0.084 DBMET01197 0.284 0.02 DBMET01198 0.217 0.058 DBMET01199 | DBMET01198 | |
| 0.234 | 0.007 | 0.266 | Opioid delta receptor antagonist | 0.205 0.01 DBMET01197 0.266 0.005 DBMET01198 | DBMET01198 | |
| 0.245 | 0.018 | 0.259 | 5 Hydroxytryptamine 3E antagonist | 0.242 0.02 DBMET01197 0.196 0.069 DBMET01198 0.259 0.013 DBMET01199 | DBMET01199 | |
| 0.251 | 0.025 | 0.251 | Acetylcholine M1 receptor antagonist | 0.239 0.028 DBMET01197 0.246 0.026 DBMET01198 0.128 0.098 DBMET01199 | ||
| 0.234 | 0.01 | 0.234 | Alpha 2a adrenoreceptor antagonist | 0.231 0.011 DBMET01197 0.208 0.013 DBMET01198 | ||
| 0.278 | 0.055 | 0.411 | HERG channel blocker | 0.411 0.026 DBMET01197 | DBMET01197 | |
| 0.238 | 0.015 | 0.276 | Antihistaminic | 0.276 0.012 DBMET01197 0.111 0.047 DBMET01198 | DBMET01197 | |
| 0.321 | 0.103 | 0.609 | Antiobesity | 0.609 0.019 DBMET01197 0.259 0.148 DBMET01198 | DBMET01197 | |
| 0.225 | 0.01 | 0.265 | Opioid antagonist | 0.173 0.02 DBMET01197 0.265 0.007 DBMET01198 | DBMET01198 | |
| 0.229 | 0.015 | 0.27 | Histamine antagonist | 0.27 0.012 DBMET01197 0.097 0.05 DBMET01198 | DBMET01197 | |
| 0.278 | 0.066 | 0.35 | Cardiotonic | 0.35 0.039 DBMET01197 0.222 0.101 DBMET01198 0.231 0.095 DBMET01199 | DBMET01197 | |
| 0.213 | 0.01 | 0.213 | 5 Hydroxytryptamine uptake inhibitor | 0.198 0.011 DBMET01197 0.107 0.024 DBMET01198 | ||
| 0.209 | 0.006 | 0.209 | Dopamine D4 agonist | 0.191 0.007 DBMET01197 0.099 0.014 DBMET01198 | ||
| 0.264 | 0.066 | 0.365 | Superoxide dismutase inhibitor | 0.271 0.063 DBMET01197 0.325 0.043 DBMET01198 0.365 0.033 DBMET01199 | DBMET01199 | |
| 0.274 | 0.079 | 0.592 | 5 Hydroxytryptamine release stimulant | 0.592 0.015 DBMET01197 0.277 0.078 DBMET01198 0.561 0.019 DBMET01199 | DBMET01197 | |
| 0.275 | 0.084 | 0.408 | Lipoxygenase inhibitor | 0.408 0.035 DBMET01198 0.265 0.09 DBMET01199 | DBMET01198 | |
| 0.208 | 0.017 | 0.214 | Alpha 2 adrenoreceptor antagonist | 0.214 0.016 DBMET01197 0.167 0.023 DBMET01198 | DBMET01197 | |
| 0.26 | 0.072 | 0.426 | Interleukin agonist | 0.305 0.045 DBMET01197 0.251 0.078 DBMET01198 0.426 0.015 DBMET01199 | DBMET01199 | |
| 0.206 | 0.018 | 0.206 | Dopamine antagonist | 0.14 0.027 DBMET01197 0.184 0.02 DBMET01198 | ||
| 0.207 | 0.019 | 0.283 | 5 Hydroxytryptamine 2A antagonist | 0.283 0.012 DBMET01197 0.119 0.038 DBMET01198 0.123 0.036 DBMET01199 | DBMET01197 | |
| 0.188 | 0.004 | 0.272 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.161 0.004 DBMET01197 0.272 0.003 DBMET01198 0.082 0.018 DBMET01199 | DBMET01198 | |
| 0.264 | 0.08 | 0.316 | Ca(v)3.3 blocker | 0.273 0.069 DBMET01197 0.316 0.031 DBMET01199 | DBMET01199 | |
| 0.26 | 0.08 | 0.294 | Transcription factor STAT inhibitor | 0.198 0.142 DBMET01197 0.294 0.059 DBMET01198 0.219 0.113 DBMET01199 | DBMET01198 | |
| 0.277 | 0.103 | 0.32 | Apoptosis antagonist | 0.243 0.134 DBMET01197 0.32 0.073 DBMET01198 | DBMET01198 | |
| 0.178 | 0.005 | 0.187 | Lanosterol 14 alpha demethylase inhibitor | 0.187 0.005 DBMET01197 0.171 0.006 DBMET01198 0.148 0.012 DBMET01199 | DBMET01197 | |
| 0.183 | 0.012 | 0.228 | Opioid kappa receptor antagonist | 0.099 0.036 DBMET01197 0.228 0.008 DBMET01198 | DBMET01198 | |
| 0.246 | 0.079 | 0.255 | 5 Hydroxytryptamine 1E antagonist | 0.255 0.07 DBMET01197 0.237 0.089 DBMET01198 0.24 0.085 DBMET01199 | DBMET01197 | |
| 0.187 | 0.023 | 0.513 | Interleukin 1b antagonist | 0.158 0.034 DBMET01198 0.513 0.004 DBMET01199 | DBMET01199 | |
| 0.182 | 0.018 | 0.182 | Dopamine D2 antagonist | 0.124 0.027 DBMET01197 0.162 0.021 DBMET01198 | ||
| 0.194 | 0.03 | 0.201 | Neurotrophic factor | 0.201 0.027 DBMET01197 0.182 0.036 DBMET01198 | DBMET01197 | |
| 0.236 | 0.074 | 0.352 | Potassium channel (Voltage-sensitive) blocker | 0.352 0.036 DBMET01197 | DBMET01197 | |
| 0.246 | 0.085 | 0.488 | 5 Hydroxytryptamine uptake stimulant | 0.469 0.005 DBMET01197 0.239 0.092 DBMET01198 0.488 0.005 DBMET01199 | DBMET01199 | |
| 0.176 | 0.017 | 0.234 | Alpha 1b adrenoreceptor antagonist | 0.234 0.011 DBMET01197 0.138 0.024 DBMET01198 | DBMET01197 | |
| 0.174 | 0.021 | 0.259 | 5 Hydroxytryptamine 2C antagonist | 0.259 0.012 DBMET01197 0.104 0.043 DBMET01198 0.111 0.04 DBMET01199 | DBMET01197 | |
| 0.24 | 0.091 | 0.266 | Transcription factor STAT3 inhibitor | 0.179 0.165 DBMET01197 0.266 0.072 DBMET01198 0.213 0.118 DBMET01199 | DBMET01198 | |
| 0.165 | 0.017 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.166 0.016 DBMET01197 0.164 0.018 DBMET01198 0.165 0.018 DBMET01199 | DBMET01197 | |
| 0.146 | 0.008 | 0.172 | Opioid agonist | 0.149 0.007 DBMET01197 0.172 0.006 DBMET01198 | DBMET01198 | |
| 0.144 | 0.008 | 0.144 | Acetylcholine M5 receptor antagonist | 0.144 0.008 DBMET01197 0.122 0.012 DBMET01198 0.059 0.044 DBMET01199 | ||
| 0.153 | 0.025 | 0.203 | Nav1.5 sodium channel blocker | 0.203 0.012 DBMET01197 0.122 0.052 DBMET01198 0.161 0.022 DBMET01199 | DBMET01197 | |
| 0.14 | 0.019 | 0.182 | Opioid mu receptor antagonist | 0.085 0.038 DBMET01197 0.182 0.011 DBMET01198 | DBMET01198 | |
| 0.137 | 0.017 | 0.224 | Dopamine D1 antagonist | 0.092 0.028 DBMET01197 0.224 0.009 DBMET01198 0.074 0.036 DBMET01199 | DBMET01198 | |
| 0.134 | 0.014 | 0.157 | Acetylcholine M4 receptor antagonist | 0.157 0.009 DBMET01197 0.085 0.041 DBMET01198 0.078 0.048 DBMET01199 | DBMET01197 | |
| 0.125 | 0.005 | 0.125 | Potassium channel (Tandem pore domain) blocker | 0.118 0.005 DBMET01197 0.086 0.022 DBMET01198 0.095 0.012 DBMET01199 | ||
| 0.155 | 0.036 | 0.183 | Alpha adrenoreceptor antagonist | 0.183 0.03 DBMET01197 0.113 0.05 DBMET01198 | DBMET01197 | |
| 0.123 | 0.008 | 0.123 | Dopamine transporter inhibitor | 0.105 0.011 DBMET01197 0.091 0.014 DBMET01198 0.059 0.025 DBMET01199 | ||
| 0.143 | 0.029 | 0.143 | Multidrug resistance-associated protein 1 inhibitor | 0.121 0.047 DBMET01197 0.136 0.033 DBMET01198 0.119 0.049 DBMET01199 | ||
| 0.163 | 0.05 | 0.564 | Interleukin 1 antagonist | 0.148 0.059 DBMET01198 0.564 0.004 DBMET01199 | DBMET01199 | |
| 0.116 | 0.01 | 0.116 | Melanin-concentrating hormone receptor 1 antagonist | 0.059 0.031 DBMET01197 0.052 0.038 DBMET01198 | ||
| 0.114 | 0.008 | 0.114 | CC chemokine 3 receptor antagonist | 0.108 0.009 DBMET01197 0.063 0.018 DBMET01198 0.049 0.024 DBMET01199 | ||
| 0.125 | 0.02 | 0.135 | Cannabinoid receptor antagonist | 0.135 0.017 DBMET01197 0.071 0.048 DBMET01198 0.129 0.019 DBMET01199 | DBMET01197 | |
| 0.122 | 0.02 | 0.14 | Dopamine agonist | 0.089 0.032 DBMET01197 0.14 0.016 DBMET01198 | DBMET01198 | |
| 0.105 | 0.004 | 0.105 | GABA uptake inhibitor | 0.08 0.005 DBMET01197 0.091 0.004 DBMET01198 0.042 0.023 DBMET01199 | ||
| 0.132 | 0.032 | 0.14 | Acetylcholine release stimulant | 0.135 0.028 DBMET01197 0.102 0.082 DBMET01198 0.14 0.024 DBMET01199 | DBMET01199 | |
| 0.105 | 0.005 | 0.133 | Opioid delta receptor agonist | 0.133 0.005 DBMET01197 0.131 0.005 DBMET01198 | DBMET01197 | |
| 0.173 | 0.073 | 0.328 | Tumour necrosis factor antagonist | 0.198 0.055 DBMET01197 0.168 0.079 DBMET01198 0.328 0.013 DBMET01199 | DBMET01199 | |
| 0.161 | 0.063 | 0.227 | NOS3 expression enhancer | 0.227 0.032 DBMET01198 0.206 0.039 DBMET01199 | DBMET01198 | |
| 0.224 | 0.127 | 0.342 | 12-Lipoxygenase inhibitor | 0.342 0.06 DBMET01198 0.232 0.121 DBMET01199 | DBMET01198 | |
| 0.134 | 0.037 | 0.163 | Mediator release inhibitor | 0.089 0.082 DBMET01197 0.163 0.023 DBMET01198 | DBMET01198 | |
| 0.143 | 0.048 | 0.185 | Cholesterol synthesis inhibitor | 0.185 0.031 DBMET01198 0.128 0.058 DBMET01199 | DBMET01198 | |
| 0.221 | 0.128 | 0.329 | Hypoxia-inducible factor 1 alpha inhibitor | 0.329 0.053 DBMET01197 0.292 0.07 DBMET01198 0.283 0.075 DBMET01199 | DBMET01197 | |
| 0.108 | 0.016 | 0.117 | Ca(v)3.1 blocker | 0.117 0.012 DBMET01197 0.1 0.023 DBMET01198 | DBMET01197 | |
| 0.112 | 0.02 | 0.165 | Alpha 1d adrenoreceptor antagonist | 0.165 0.013 DBMET01197 0.075 0.033 DBMET01198 | DBMET01197 | |
| 0.103 | 0.015 | 0.118 | Cannabinoid CB1 receptor antagonist | 0.118 0.012 DBMET01197 0.064 0.04 DBMET01198 0.107 0.014 DBMET01199 | DBMET01197 | |
| 0.092 | 0.005 | 0.098 | Adenylate cyclase 1 inhibitor | 0.046 0.032 DBMET01197 0.087 0.006 DBMET01198 0.098 0.004 DBMET01199 | DBMET01199 | |
| 0.11 | 0.027 | 0.308 | 5 Hydroxytryptamine 1F antagonist | 0.308 0.005 DBMET01197 0.06 0.059 DBMET01198 0.11 0.027 DBMET01199 | DBMET01197 | |
| 0.186 | 0.106 | 0.196 | ErbB-1 antagonist | 0.194 0.096 DBMET01198 0.196 0.094 DBMET01199 | DBMET01199 | |
| 0.194 | 0.114 | 0.284 | Tumour necrosis factor alpha release inhibitor | 0.2 0.109 DBMET01198 0.284 0.06 DBMET01199 | DBMET01199 | |
| 0.096 | 0.017 | 0.141 | Phospholipase D inhibitor | 0.135 0.004 DBMET01197 0.074 0.045 DBMET01198 0.141 0.004 DBMET01199 | DBMET01199 | |
| 0.092 | 0.018 | 0.092 | Sigma receptor antagonist | 0.066 0.025 DBMET01198 | ||
| 0.109 | 0.035 | 0.109 | Alpha 2d adrenoreceptor antagonist | 0.098 0.051 DBMET01197 0.093 0.063 DBMET01198 | ||
| 0.167 | 0.093 | 0.189 | P-glycoprotein inhibitor | 0.173 0.087 DBMET01198 0.189 0.072 DBMET01199 | DBMET01199 | |
| 0.237 | 0.163 | 0.477 | Calcium channel activator | 0.334 0.062 DBMET01197 0.218 0.188 DBMET01198 0.477 0.007 DBMET01199 | DBMET01199 | |
| 0.144 | 0.071 | 0.16 | Cell wall synthesis inhibitor | 0.136 0.079 DBMET01197 0.16 0.057 DBMET01198 0.14 0.075 DBMET01199 | DBMET01198 | |
| 0.126 | 0.061 | 0.141 | Acetylcholine muscarinic antagonist | 0.141 0.049 DBMET01197 0.124 0.063 DBMET01198 | DBMET01197 | |
| 0.121 | 0.058 | 0.136 | Transcription factor STAT6 inhibitor | 0.124 0.053 DBMET01197 0.128 0.047 DBMET01198 0.136 0.037 DBMET01199 | DBMET01199 | |
| 0.134 | 0.071 | 0.25 | Sodium channel blocker | 0.25 0.018 DBMET01197 0.151 0.058 DBMET01199 | DBMET01197 | |
| 0.113 | 0.054 | 0.184 | 5-Lipoxygenase inhibitor | 0.184 0.028 DBMET01198 | DBMET01198 | |
| 0.101 | 0.043 | 0.186 | Alpha 1 adrenoreceptor antagonist | 0.186 0.023 DBMET01197 0.068 0.061 DBMET01198 | DBMET01197 | |
| 0.076 | 0.018 | 0.095 | Calcium channel P-type blocker | 0.095 0.007 DBMET01197 0.064 0.043 DBMET01198 0.071 0.026 DBMET01199 | DBMET01197 | |
| 0.108 | 0.051 | 0.155 | Antiadrenergic | 0.155 0.034 DBMET01197 0.095 0.059 DBMET01198 | DBMET01197 | |
| 0.11 | 0.055 | 0.134 | Toll-Like receptor 4 antagonist | 0.134 0.031 DBMET01198 | DBMET01198 | |
| 0.276 | 0.221 | 0.452 | Caspase 9 stimulant | 0.308 0.186 DBMET01197 0.335 0.158 DBMET01198 0.452 0.082 DBMET01199 | DBMET01199 | |
| 0.115 | 0.06 | 0.248 | 5 Hydroxytryptamine 3A agonist | 0.248 0.005 DBMET01197 0.097 0.08 DBMET01198 0.213 0.012 DBMET01199 | DBMET01197 | |
| 0.105 | 0.051 | 0.152 | Adrenaline antagonist | 0.152 0.034 DBMET01197 0.093 0.058 DBMET01198 | DBMET01197 | |
| 0.058 | 0.005 | 0.114 | Nociceptin (N/OFQ) receptor agonist | 0.114 0.004 DBMET01197 0.035 0.009 DBMET01198 | DBMET01197 | |
| 0.138 | 0.088 | 0.162 | Phospholipase A2 inhibitor | 0.162 0.064 DBMET01198 0.154 0.07 DBMET01199 | DBMET01198 | |
| 0.181 | 0.131 | 0.329 | Antioxidant | 0.329 0.052 DBMET01198 | DBMET01198 | |
| 0.125 | 0.079 | 0.232 | Sodium channel (voltage-gated) blocker | 0.232 0.019 DBMET01197 0.17 0.042 DBMET01199 | DBMET01197 | |
| 0.113 | 0.069 | 0.243 | 5 Hydroxytryptamine antagonist | 0.243 0.026 DBMET01197 | DBMET01197 | |
| 0.121 | 0.078 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | 0.143 0.041 DBMET01198 0.127 0.066 DBMET01199 | DBMET01198 | |
| 0.052 | 0.011 | 0.1 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.034 0.02 DBMET01197 0.1 0.004 DBMET01198 | DBMET01198 | |
| 0.071 | 0.034 | 0.14 | Adrenaline uptake inhibitor | 0.14 0.01 DBMET01197 | DBMET01197 | |
| 0.057 | 0.021 | 0.065 | Dopamine D5 antagonist | 0.065 0.017 DBMET01198 | DBMET01198 | |
| 0.126 | 0.091 | 0.335 | Mannose-6-phosphate isomerase inhibitor | 0.169 0.05 DBMET01197 0.12 0.101 DBMET01198 0.335 0.004 DBMET01199 | DBMET01199 | |
| 0.201 | 0.167 | 0.272 | Caspase 3 stimulant | 0.272 0.095 DBMET01198 | DBMET01198 | |
| 0.069 | 0.038 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.035 DBMET01199 | DBMET01199 | |
| 0.204 | 0.172 | 0.256 | Antithrombotic | 0.224 0.15 DBMET01198 0.256 0.122 DBMET01199 | DBMET01199 | |
| 0.1 | 0.071 | 0.36 | Ferrochelatase inhibitor | 0.209 0.02 DBMET01197 0.36 0.004 DBMET01199 | DBMET01199 | |
| 0.219 | 0.192 | 0.339 | 15-Lipoxygenase inhibitor | 0.339 0.106 DBMET01198 0.328 0.112 DBMET01199 | DBMET01198 | |
| 0.067 | 0.04 | 0.115 | 5 Hydroxytryptamine 7 antagonist | 0.115 0.022 DBMET01197 | DBMET01197 | |
| 0.052 | 0.026 | 0.085 | Dopamine beta hydroxylase inhibitor | 0.081 0.005 DBMET01197 0.061 0.014 DBMET01198 0.085 0.005 DBMET01199 | DBMET01199 | |
| 0.082 | 0.057 | 0.094 | CC chemokine 5 receptor agonist | 0.085 0.049 DBMET01197 0.089 0.038 DBMET01198 0.094 0.03 DBMET01199 | DBMET01199 | |
| 0.056 | 0.031 | 0.128 | Dipeptidyl peptidase inhibitor | 0.128 0.005 DBMET01197 0.049 0.046 DBMET01199 | DBMET01197 | |
| 0.073 | 0.049 | 0.15 | Alpha 1a adrenoreceptor antagonist | 0.15 0.023 DBMET01197 | DBMET01197 | |
| 0.058 | 0.035 | 0.065 | Leukotriene C antagonist | 0.061 0.028 DBMET01198 0.065 0.02 DBMET01199 | DBMET01199 | |
| 0.063 | 0.041 | 0.076 | 5 Hydroxytryptamine 5A antagonist | 0.076 0.026 DBMET01197 0.07 0.031 DBMET01199 | DBMET01197 | |
| 0.107 | 0.086 | 0.149 | Cholinergic antagonist | 0.149 0.053 DBMET01197 0.1 0.096 DBMET01198 | DBMET01197 | |
| 0.051 | 0.031 | 0.094 | Glycine transporter inhibitor | 0.094 0.013 DBMET01197 0.062 0.024 DBMET01199 | DBMET01197 | |
| 0.091 | 0.071 | 0.204 | Creatine kinase inhibitor | 0.118 0.042 DBMET01197 0.16 0.02 DBMET01198 0.204 0.01 DBMET01199 | DBMET01199 | |
| 0.04 | 0.021 | 0.057 | 5 Hydroxytryptamine 3B antagonist | 0.057 0.012 DBMET01197 | DBMET01197 | |
| 0.136 | 0.119 | 0.261 | Amyloid beta aggregation inhibitor | 0.261 0.054 DBMET01198 | DBMET01198 | |
| 0.061 | 0.044 | 0.066 | Heme oxygenase stimulant | 0.066 0.032 DBMET01198 | DBMET01198 | |
| 0.027 | 0.012 | 0.027 | CYP24 inhibitor | 0.026 0.013 DBMET01198 | ||
| 0.046 | 0.032 | 0.08 | Opioid mu receptor agonist | 0.08 0.018 DBMET01198 | DBMET01198 | |
| 0.103 | 0.089 | 0.142 | Acetylcholine antagonist | 0.142 0.055 DBMET01197 | DBMET01197 | |
| 0.074 | 0.06 | 0.149 | Macrophage migration inhibitory factor inhibitor | 0.082 0.049 DBMET01197 0.149 0.015 DBMET01198 0.105 0.032 DBMET01199 | DBMET01198 | |
| 0.045 | 0.032 | 0.06 | Oleamide hydrolase inhibitor | 0.06 0.02 DBMET01199 | DBMET01199 | |
| 0.044 | 0.032 | 0.098 | Dipeptidyl peptidase IV inhibitor | 0.098 0.005 DBMET01197 0.042 0.037 DBMET01199 | DBMET01197 | |
| 0.057 | 0.046 | 0.069 | Acetylcholine M3 receptor antagonist | 0.069 0.032 DBMET01197 0.066 0.035 DBMET01198 | DBMET01197 | |
| 0.023 | 0.012 | 0.029 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.029 0.01 DBMET01198 | DBMET01198 | |
| 0.148 | 0.137 | 0.226 | Potassium channel blocker | 0.226 0.078 DBMET01197 | DBMET01197 | |
| 0.089 | 0.079 | 0.124 | Phosphodiesterase 6D inhibitor | 0.088 0.083 DBMET01197 0.093 0.067 DBMET01198 0.124 0.021 DBMET01199 | DBMET01199 | |
| 0.106 | 0.096 | 0.106 | Acetylcholinesterase inhibitor | 0.104 0.098 DBMET01198 | ||
| 0.055 | 0.046 | 0.068 | 5 Hydroxytryptamine 5 antagonist | 0.068 0.028 DBMET01197 0.063 0.033 DBMET01199 | DBMET01197 | |
| 0.059 | 0.05 | 0.115 | 5 Hydroxytryptamine 3 agonist | 0.115 0.01 DBMET01197 0.073 0.033 DBMET01199 | DBMET01197 | |
| 0.105 | 0.098 | 0.153 | Cathepsin H inhibitor | 0.153 0.044 DBMET01199 | DBMET01199 | |
| 0.057 | 0.05 | 0.093 | NMDA 2C receptor antagonist | 0.093 0.018 DBMET01197 0.069 0.034 DBMET01198 | DBMET01197 | |
| 0.034 | 0.03 | 0.056 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.056 0.008 DBMET01199 | DBMET01199 | |
| 0.026 | 0.023 | 0.028 | Thrombin receptor antagonist | 0.028 0.02 DBMET01199 | DBMET01199 | |
| 0.031 | 0.028 | 0.048 | Nociceptin (N/OFQ) receptor antagonist | 0.048 0.015 DBMET01197 | DBMET01197 | |
| 0.063 | 0.061 | 0.102 | MDM2 inhibitor | 0.076 0.025 DBMET01197 0.102 0.006 DBMET01199 | DBMET01199 | |
| 0.068 | 0.066 | 0.14 | CC chemokine receptor antagonist | 0.077 0.055 DBMET01197 0.14 0.02 DBMET01199 | DBMET01199 | |
| 0.106 | 0.104 | 0.129 | Sphingosine 1-phosphate receptor 4 antagonist | 0.129 0.057 DBMET01199 | DBMET01199 | |
| 0.014 | 0.013 | 0.03 | Dipeptidyl peptidase VIII inhibitor | 0.03 0.005 DBMET01197 | DBMET01197 | |
| 0.022 | 0.021 | 0.029 | Methionyl aminopeptidase 2 inhibitor | 0.029 0.015 DBMET01199 | DBMET01199 | |
| 0.036 | 0.035 | 0.118 | Estradiol 17 beta-dehydrogenase inhibitor | 0.099 0.01 DBMET01198 0.118 0.009 DBMET01199 | DBMET01199 | |
| 0.04 | 0.041 | 0.047 | Heme oxygenase inhibitor | 0.043 0.03 DBMET01197 0.047 0.019 DBMET01199 | DBMET01199 | |
| 0.068 | 0.07 | 0.106 | Vanilloid 4 agonist | 0.087 0.029 DBMET01197 0.106 0.013 DBMET01199 | DBMET01199 | |
| 0.052 | 0.055 | 0.09 | Pregnane X receptor antagonist | 0.056 0.04 DBMET01197 0.09 0.004 DBMET01199 | DBMET01199 | |
| 0.032 | 0.036 | 0.042 | Glutamate (mGluR8) antagonist | 0.042 0.015 DBMET01197 | DBMET01197 | |
| 0.07 | 0.076 | 0.121 | Viral attachment inhibitor | 0.121 0.014 DBMET01197 | DBMET01197 | |
| 0.037 | 0.043 | 0.046 | Kainate receptor agonist | 0.046 0.02 DBMET01199 | DBMET01199 | |
| 0.047 | 0.055 | 0.052 | Thromboxane synthase inhibitor | 0.052 0.043 DBMET01199 | DBMET01199 | |
| 0.045 | 0.052 | 0.082 | Aromatase inhibitor | 0.066 0.037 DBMET01198 0.082 0.027 DBMET01199 | DBMET01199 | |
| 0.053 | 0.061 | 0.091 | 5 Hydroxytryptamine 1A antagonist | 0.091 0.035 DBMET01197 | DBMET01197 | |
| 0.063 | 0.072 | 0.118 | Nicotinic alpha4beta2 receptor antagonist | 0.118 0.019 DBMET01197 0.079 0.051 DBMET01199 | DBMET01197 | |
| 0.027 | 0.036 | 0.059 | Dipeptidyl peptidase II inhibitor | 0.059 0.007 DBMET01197 0.036 0.017 DBMET01199 | DBMET01197 | |
| 0.096 | 0.106 | 0.261 | Aldehyde dehydrogenase inhibitor | 0.135 0.057 DBMET01198 0.261 0.016 DBMET01199 | DBMET01199 | |
| 0.033 | 0.047 | 0.043 | 5 Hydroxytryptamine 1A agonist | 0.043 0.035 DBMET01197 | DBMET01197 | |
| 0.023 | 0.039 | 0.038 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET01197 0.031 0.013 DBMET01198 0.035 0.008 DBMET01199 | DBMET01197 | |
| 0.01 | 0.026 | 0.02 | Dipeptidyl peptidase IX inhibitor | 0.02 0.008 DBMET01197 | DBMET01197 | |
| 0.174 | 0.191 | 0.291 | Tyrosine 3 hydroxylase inhibitor | 0.24 0.079 DBMET01197 0.221 0.102 DBMET01198 0.291 0.038 DBMET01199 | DBMET01199 | |
| 0.031 | 0.049 | 0.043 | Histone deacetylase 9 inhibitor | 0.043 0.021 DBMET01199 | DBMET01199 | |
| 0.026 | 0.044 | 0.034 | HMG CoA reductase inhibitor | 0.034 0.025 DBMET01199 | DBMET01199 | |
| 0.204 | 0.223 | 0.228 | Transcription factor inhibitor | 0.228 0.203 DBMET01199 | DBMET01199 | |
| 0.053 | 0.073 | 0.098 | 5 Hydroxytryptamine 1 antagonist | 0.098 0.038 DBMET01197 | DBMET01197 | |
| 0.16 | 0.18 | 0.347 | Nitric-oxide synthase stimulant | 0.263 0.025 DBMET01197 0.179 0.131 DBMET01198 0.347 0.005 DBMET01199 | DBMET01199 | |
| 0.13 | 0.15 | 0.416 | Non-steroidal antiinflammatory agent | 0.146 0.121 DBMET01197 0.137 0.135 DBMET01198 0.416 0.012 DBMET01199 | DBMET01199 | |
| 0.026 | 0.045 | 0.062 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.036 0.021 DBMET01197 0.062 0.005 DBMET01199 | DBMET01199 | |
| 0.013 | 0.034 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.013 DBMET01199 | DBMET01199 | |
| 0.013 | 0.034 | 0.026 | 5-Alpha-reductase 2 inhibitor | 0.026 0.01 DBMET01199 | DBMET01199 | |
| 0.043 | 0.065 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.029 DBMET01197 0.059 0.028 DBMET01199 | DBMET01199 | |
| 0.027 | 0.049 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET01197 0.039 0.018 DBMET01199 | DBMET01197 | |
| 0.138 | 0.162 | 0.305 | Free radical scavenger | 0.305 0.051 DBMET01198 | DBMET01198 | |
| 0.031 | 0.055 | 0.045 | Carbonic anhydrase VII inhibitor | 0.045 0.034 DBMET01198 | DBMET01198 | |
| 0.05 | 0.075 | 0.092 | NMDA 2 receptor antagonist | 0.092 0.036 DBMET01198 | DBMET01198 | |
| 0.029 | 0.054 | 0.041 | Glycine transporter 2 inhibitor | 0.041 0.038 DBMET01198 | DBMET01198 | |
| 0.15 | 0.178 | 0.227 | Hypoglycemic | 0.227 0.092 DBMET01198 0.203 0.109 DBMET01199 | DBMET01198 | |
| 0.041 | 0.069 | 0.11 | Alpha 1 adrenoreceptor agonist | 0.11 0.014 DBMET01197 0.055 0.042 DBMET01199 | DBMET01197 | |
| 0.024 | 0.056 | 0.042 | Histone deacetylase 7 inhibitor | 0.042 0.022 DBMET01199 | DBMET01199 | |
| 0.069 | 0.102 | 0.091 | Prolactin inhibitor | 0.091 0.066 DBMET01198 | DBMET01198 | |
| 0.09 | 0.124 | 0.173 | Estrogen antagonist | 0.173 0.017 DBMET01198 0.143 0.026 DBMET01199 | DBMET01198 | |
| 0.008 | 0.043 | 0.028 | 5-Alpha-reductase 1 inhibitor | 0.028 0.009 DBMET01199 | DBMET01199 | |
| 0.046 | 0.082 | 0.149 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.05 DBMET01197 0.149 0.004 DBMET01199 | DBMET01199 | |
| 0.048 | 0.085 | 0.213 | Catalase inhibitor | 0.213 0.013 DBMET01199 | DBMET01199 | |
| 0.076 | 0.114 | 0.187 | Adenylate cyclase inhibitor | 0.098 0.086 DBMET01198 0.187 0.028 DBMET01199 | DBMET01199 | |
| 0.086 | 0.125 | 0.336 | Alpha-N-acetylglucosaminidase inhibitor | 0.194 0.036 DBMET01197 0.336 0.013 DBMET01199 | DBMET01199 | |
| 0.113 | 0.152 | 0.231 | Interferon gamma antagonist | 0.138 0.095 DBMET01198 0.231 0.032 DBMET01199 | DBMET01199 | |
| 0.056 | 0.095 | 0.097 | GABA aminotransferase inhibitor | 0.069 0.063 DBMET01198 0.097 0.03 DBMET01199 | DBMET01199 | |
| 0.022 | 0.062 | 0.053 | Histamine H3 receptor antagonist | 0.053 0.025 DBMET01197 | DBMET01197 | |
| 0.06 | 0.1 | 0.094 | NMDA receptor antagonist | 0.094 0.051 DBMET01198 | DBMET01198 | |
| 0.042 | 0.084 | 0.066 | 5 Hydroxytryptamine 7 agonist | 0.066 0.024 DBMET01197 0.055 0.04 DBMET01199 | DBMET01197 | |
| 0.068 | 0.11 | 0.273 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.108 0.047 DBMET01197 0.273 0.008 DBMET01199 | DBMET01199 | |
| 0.035 | 0.081 | 0.088 | 5 Hydroxytryptamine 3 antagonist | 0.088 0.021 DBMET01197 | DBMET01197 | |
| 0.011 | 0.059 | 0.122 | Glutamate (mGluR1a) agonist | 0.024 0.014 DBMET01197 0.122 0.003 DBMET01199 | DBMET01199 | |
| 0.058 | 0.106 | 0.166 | Myeloperoxidase inhibitor | 0.086 0.055 DBMET01197 0.166 0.008 DBMET01199 | DBMET01199 | |
| 0.009 | 0.058 | 0.02 | Prostaglandin EP2 agonist | 0.02 0.018 DBMET01199 | DBMET01199 | |
| 0.21 | 0.26 | 0.322 | Apoptosis agonist | 0.322 0.157 DBMET01198 | DBMET01198 | |
| 0.084 | 0.135 | 0.146 | Cytokine production inhibitor | 0.146 0.065 DBMET01197 0.129 0.08 DBMET01199 | DBMET01197 | |
| 0.068 | 0.12 | 0.253 | GABA C receptor agonist | 0.2 0.02 DBMET01197 0.253 0.013 DBMET01199 | DBMET01199 | |
| 0.122 | 0.174 | 0.136 | Heat shock protein 70 antagonist | 0.131 0.117 DBMET01198 0.136 0.089 DBMET01199 | DBMET01199 | |
| 0.032 | 0.085 | 0.125 | Cannabinoid CB1 receptor agonist | 0.057 0.045 DBMET01197 0.125 0.013 DBMET01199 | DBMET01199 | |
| 0.02 | 0.073 | 0.045 | Secretase gamma inhibitor | 0.045 0.029 DBMET01199 | DBMET01199 | |
| 0.036 | 0.089 | 0.119 | 5 Hydroxytryptamine 2A agonist | 0.119 0.009 DBMET01197 0.08 0.028 DBMET01199 | DBMET01197 | |
| 0.072 | 0.126 | 0.235 | Glutamate release inhibitor | 0.093 0.055 DBMET01197 0.235 0.004 DBMET01199 | DBMET01199 | |
| 0.029 | 0.083 | 0.093 | Glutamate (mGluR5) agonist | 0.042 0.038 DBMET01197 0.093 0.008 DBMET01199 | DBMET01199 | |
| 0.024 | 0.077 | 0.04 | Delayed rectifier potassium channel blocker | 0.04 0.022 DBMET01199 | DBMET01199 | |
| 0.189 | 0.243 | 0.256 | Antibacterial | 0.256 0.171 DBMET01198 | DBMET01198 | |
| 0.079 | 0.133 | 0.28 | DOPA decarboxylase inhibitor | 0.111 0.056 DBMET01197 0.117 0.049 DBMET01198 0.28 0.003 DBMET01199 | DBMET01199 | |
| 0.027 | 0.082 | 0.083 | 5 Hydroxytryptamine 2B agonist | 0.083 0.005 DBMET01197 0.051 0.013 DBMET01199 | DBMET01197 | |
| 0.027 | 0.083 | 0.043 | Nerve growth factor antagonist | 0.043 0.03 DBMET01199 | DBMET01199 | |
| 0.016 | 0.073 | 0.049 | Acid ceramidase inhibitor | 0.03 0.01 DBMET01197 0.049 0.003 DBMET01199 | DBMET01199 | |
| 0.179 | 0.237 | 0.447 | GABA C receptor rho-3 antagonist | 0.277 0.132 DBMET01197 0.447 0.043 DBMET01199 | DBMET01199 | |
| 0.104 | 0.162 | 0.154 | Heat shock protein 90 alpha antagonist | 0.154 0.083 DBMET01198 | DBMET01198 | |
| 0.034 | 0.094 | 0.055 | CC chemokine receptor 2B antagonist | 0.055 0.024 DBMET01197 | DBMET01197 | |
| 0.178 | 0.238 | 0.29 | Alpha-glucosidase inhibitor | 0.29 0.165 DBMET01198 0.228 0.201 DBMET01199 | DBMET01198 | |
| 0.075 | 0.138 | 0.401 | Cyclooxygenase 1 inhibitor | 0.116 0.085 DBMET01198 0.401 0.007 DBMET01199 | DBMET01199 | |
| 0.074 | 0.138 | 0.157 | Glutamate (mGluR7) agonist | 0.11 0.042 DBMET01197 0.157 0.01 DBMET01199 | DBMET01199 | |
| 0.01 | 0.074 | 0.032 | Imidazoline I1 receptor antagonist | 0.032 0.006 DBMET01197 0.021 0.014 DBMET01199 | DBMET01197 | |
| 0.067 | 0.132 | 0.185 | Cystathionine beta-synthase inhibitor | 0.129 0.051 DBMET01198 0.185 0.028 DBMET01199 | DBMET01199 | |
| 0.049 | 0.114 | 0.076 | Transcription factor RelA inhibitor | 0.076 0.022 DBMET01199 | DBMET01199 | |
| 0.119 | 0.184 | 0.217 | Succinate dehydrogenase inhibitor | 0.217 0.037 DBMET01199 | DBMET01199 | |
| 0.132 | 0.197 | 0.198 | Streptokinase A inhibitor | 0.198 0.134 DBMET01198 | DBMET01198 | |
| 0.017 | 0.083 | 0.035 | 5 Hydroxytryptamine 6 agonist | 0.035 0.011 DBMET01197 0.027 0.023 DBMET01199 | DBMET01197 | |
| 0.017 | 0.084 | 0.027 | Complement factor 1s inhibitor | 0.027 0.014 DBMET01199 | DBMET01199 | |
| 0.1 | 0.168 | 0.133 | Thiol protease inhibitor | 0.121 0.115 DBMET01197 0.133 0.091 DBMET01199 | DBMET01199 | |
| 0.057 | 0.124 | 0.12 | Estrogen receptor alpha antagonist | 0.087 0.039 DBMET01198 0.12 0.019 DBMET01199 | DBMET01199 | |
| 0.05 | 0.118 | 0.134 | Exportin-1 inhibitor | 0.134 0.004 DBMET01199 | DBMET01199 | |
| 0.032 | 0.101 | 0.06 | Leukotriene B4 antagonist | 0.06 0.028 DBMET01199 | DBMET01199 | |
| 0.022 | 0.091 | 0.061 | Thromboxane A2 antagonist | 0.061 0.027 DBMET01199 | DBMET01199 | |
| 0.016 | 0.084 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 DBMET01199 | DBMET01199 | |
| 0.025 | 0.094 | 0.054 | Carbonic anhydrase XIV inhibitor | 0.054 0.029 DBMET01199 | DBMET01199 | |
| 0.02 | 0.09 | 0.047 | Dopamine D5 agonist | 0.047 0.02 DBMET01197 0.047 0.02 DBMET01199 | DBMET01199 | |
| 0.006 | 0.076 | 0.026 | Cyclin T1 inhibitor | 0.024 0.008 DBMET01197 0.026 0.007 DBMET01199 | DBMET01199 | |
| 0.004 | 0.075 | 0.025 | Imidazoline I2 receptor antagonist | 0.011 0.007 DBMET01197 0.025 0.003 DBMET01199 | DBMET01199 | |
| 0.041 | 0.112 | 0.084 | Protein kinase C beta inhibitor | 0.084 0.025 DBMET01197 0.079 0.031 DBMET01199 | DBMET01197 | |
| 0.016 | 0.088 | 0.035 | MAP3K8 inhibitor | 0.03 0.018 DBMET01197 0.035 0.01 DBMET01199 | DBMET01199 | |
| 0.032 | 0.103 | 0.087 | Carbamoyl phosphate synthetase inhibitor | 0.087 0.025 DBMET01199 | DBMET01199 | |
| 0.06 | 0.133 | 0.225 | Triose-phosphate isomerase inhibitor | 0.089 0.061 DBMET01197 0.225 0.008 DBMET01199 | DBMET01199 | |
| 0.032 | 0.105 | 0.08 | TRPA1 antagonist | 0.08 0.025 DBMET01199 | DBMET01199 | |
| 0.035 | 0.108 | 0.059 | 5 Hydroxytryptamine 1B antagonist | 0.059 0.053 DBMET01197 | DBMET01197 | |
| 0.006 | 0.08 | 0.025 | Alpha 2a adrenoreceptor agonist | 0.025 0.006 DBMET01197 0.023 0.007 DBMET01199 | DBMET01197 | |
| 0.014 | 0.088 | 0.049 | CDK4/cyclin D3 inhibitor | 0.03 0.018 DBMET01197 0.049 0.007 DBMET01199 | DBMET01199 | |
| 0.008 | 0.083 | 0.019 | Complement factor D inhibitor | 0.019 0.011 DBMET01199 | DBMET01199 | |
| 0.028 | 0.103 | 0.043 | Leukotriene C4 antagonist | 0.043 0.018 DBMET01199 | DBMET01199 | |
| 0.035 | 0.11 | 0.087 | 5 Hydroxytryptamine 3A antagonist | 0.087 0.025 DBMET01197 | DBMET01197 | |
| 0.065 | 0.141 | 0.117 | Potassium channel (Voltage-sensitive) activator | 0.117 0.035 DBMET01199 | DBMET01199 | |
| 0.013 | 0.089 | 0.046 | 5-Alpha-reductase inhibitor | 0.046 0.02 DBMET01199 | DBMET01199 | |
| 0.068 | 0.145 | 0.305 | Amylase inhibitor | 0.135 0.072 DBMET01198 0.305 0.018 DBMET01199 | DBMET01199 | |
| 0.056 | 0.134 | 0.144 | Chemokine receptor antagonist | 0.096 0.067 DBMET01197 0.144 0.035 DBMET01199 | DBMET01199 | |
| 0.012 | 0.091 | 0.029 | Retinoid X beta receptor antagonist | 0.029 0.005 DBMET01199 | DBMET01199 | |
| 0.024 | 0.104 | 0.062 | Thromboxane antagonist | 0.062 0.031 DBMET01199 | DBMET01199 | |
| 0.027 | 0.107 | 0.05 | Histamine H1 receptor agonist | 0.048 0.021 DBMET01197 0.05 0.019 DBMET01199 | DBMET01199 | |
| 0.018 | 0.098 | 0.073 | Alpha 1d adrenoreceptor agonist | 0.073 0.006 DBMET01197 0.071 0.007 DBMET01199 | DBMET01197 | |
| 0.03 | 0.112 | 0.111 | Acetylcholine M5 receptor agonist | 0.099 0.02 DBMET01197 0.111 0.014 DBMET01199 | DBMET01199 | |
| 0.141 | 0.223 | 0.25 | DNA synthesis inhibitor | 0.229 0.084 DBMET01197 0.25 0.066 DBMET01199 | DBMET01199 | |
| 0.012 | 0.096 | 0.042 | Potassium channel small-conductance Ca-activated activator | 0.04 0.015 DBMET01197 0.042 0.014 DBMET01199 | DBMET01199 | |
| 0.029 | 0.114 | 0.061 | Alpha-mannosidase inhibitor | 0.058 0.03 DBMET01197 0.061 0.025 DBMET01199 | DBMET01199 | |
| 0.04 | 0.126 | 0.087 | Aryl hydrocarbon receptor antagonist | 0.087 0.021 DBMET01199 | DBMET01199 | |
| 0.045 | 0.132 | 0.15 | HIV-1 integrase inhibitor | 0.076 0.041 DBMET01198 0.15 0.008 DBMET01199 | DBMET01199 | |
| 0.034 | 0.122 | 0.127 | Alpha adrenoreceptor agonist | 0.127 0.02 DBMET01197 | DBMET01197 | |
| 0.064 | 0.152 | 0.147 | MAP kinase kinase 1 inhibitor | 0.147 0.018 DBMET01199 | DBMET01199 | |
| 0.101 | 0.191 | 0.185 | Sphingosine 1-phosphate receptor 5 antagonist | 0.142 0.076 DBMET01197 0.185 0.02 DBMET01199 | DBMET01199 | |
| 0.018 | 0.108 | 0.093 | Glutamate (mGluR group I) agonist | 0.093 0.009 DBMET01199 | DBMET01199 | |
| 0.019 | 0.11 | 0.054 | Retinoid X alpha receptor antagonist | 0.054 0.005 DBMET01199 | DBMET01199 | |
| 0.032 | 0.123 | 0.067 | Sphingosine kinase 2 inhibitor | 0.052 0.043 DBMET01197 0.067 0.024 DBMET01199 | DBMET01199 | |
| 0.021 | 0.114 | 0.062 | Retinoid X receptor antagonist | 0.062 0.005 DBMET01199 | DBMET01199 | |
| 0.082 | 0.174 | 0.128 | Antibacterial (Helicobacter pylori) | 0.128 0.07 DBMET01199 | DBMET01199 | |
| 0.027 | 0.119 | 0.069 | Histamine agonist | 0.069 0.02 DBMET01197 | DBMET01197 | |
| 0.102 | 0.195 | 0.2 | Pregnane X receptor agonist | 0.2 0.011 DBMET01199 | DBMET01199 | |
| 0.017 | 0.111 | 0.044 | Potassium channel KCNQ activator | 0.044 0.02 DBMET01199 | DBMET01199 | |
| 0.017 | 0.111 | 0.044 | Delayed rectifier potassium channel activator | 0.044 0.02 DBMET01199 | DBMET01199 | |
| 0.019 | 0.113 | 0.073 | Potassium channel Kv1.3 blocker | 0.073 0.014 DBMET01199 | DBMET01199 | |
| 0.033 | 0.128 | 0.118 | Phenylalanine 4-hydroxylase inhibitor | 0.118 0.019 DBMET01199 | DBMET01199 | |
| 0.074 | 0.169 | 0.2 | Toll-Like receptor 2 antagonist | 0.11 0.09 DBMET01198 0.2 0.023 DBMET01199 | DBMET01199 | |
| 0.039 | 0.136 | 0.127 | MAO B inhibitor | 0.127 0.047 DBMET01199 | DBMET01199 | |
| 0.011 | 0.111 | 0.037 | Nicotinic acid receptor 2 antagonist | 0.037 0.006 DBMET01199 | DBMET01199 | |
| 0.013 | 0.113 | 0.035 | Glutamate (mGluR1) agonist | 0.035 0.007 DBMET01199 | DBMET01199 | |
| 0.031 | 0.131 | 0.094 | Neuronal nicotinic receptor antagonist | 0.094 0.027 DBMET01197 | DBMET01197 | |
| 0.089 | 0.19 | 0.223 | Pyruvate kinase inhibitor | 0.143 0.122 DBMET01198 0.223 0.07 DBMET01199 | DBMET01199 | |
| 0.063 | 0.164 | 0.114 | Beta glucuronidase inhibitor | 0.092 0.084 DBMET01198 0.114 0.052 DBMET01199 | DBMET01199 | |
| 0.014 | 0.116 | 0.04 | Histone deacetylase 8 inhibitor | 0.04 0.03 DBMET01199 | DBMET01199 | |
| 0.022 | 0.124 | 0.106 | Potassium channel Kv1.1 blocker | 0.106 0.004 DBMET01199 | DBMET01199 | |
| 0.004 | 0.107 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DBMET01199 | DBMET01199 | |
| 0.029 | 0.133 | 0.057 | Leukotriene antagonist | 0.057 0.055 DBMET01199 | DBMET01199 | |
| 0.013 | 0.117 | 0.056 | Cholesterol ester transfer protein antagonist | 0.056 0.005 DBMET01199 | DBMET01199 | |
| 0.102 | 0.206 | 0.266 | Hypolipemic | 0.266 0.061 DBMET01199 | DBMET01199 | |
| 0.066 | 0.17 | 0.162 | Microtubule formation inhibitor | 0.162 0.032 DBMET01199 | DBMET01199 | |
| 0.027 | 0.132 | 0.066 | Lysine-specific demethylase 1A inhibitor | 0.066 0.021 DBMET01199 | DBMET01199 | |
| 0.002 | 0.107 | 0.012 | Progesterone receptor A antagonist | 0.012 0.005 DBMET01199 | DBMET01199 | |
| 0.095 | 0.204 | 0.156 | Melanin inhibitor | 0.138 0.1 DBMET01198 0.156 0.074 DBMET01199 | DBMET01199 | |
| 0.05 | 0.159 | 0.102 | Histamine H2 receptor antagonist | 0.102 0.033 DBMET01199 | DBMET01199 | |
| 0.135 | 0.245 | 0.245 | Transcription factor NF kappa B inhibitor | 0.231 0.142 DBMET01198 0.245 0.131 DBMET01199 | DBMET01199 | |
| 0.026 | 0.137 | 0.101 | Aconitate hydratase inhibitor | 0.101 0.008 DBMET01199 | DBMET01199 | |
| 0.018 | 0.13 | 0.05 | Mannosidase inhibitor | 0.05 0.025 DBMET01197 0.048 0.028 DBMET01199 | DBMET01197 | |
| 0.04 | 0.152 | 0.089 | Secretase beta inhibitor | 0.068 0.053 DBMET01197 0.089 0.026 DBMET01199 | DBMET01199 | |
| 0.02 | 0.133 | 0.049 | Protein kinase (CK1) epsilon inhibitor | 0.049 0.013 DBMET01197 0.043 0.02 DBMET01199 | DBMET01197 | |
| 0.035 | 0.15 | 0.079 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET01199 | DBMET01199 | |
| 0.043 | 0.159 | 0.111 | Glycine receptor antagonist | 0.097 0.035 DBMET01197 0.111 0.024 DBMET01199 | DBMET01199 | |
| 0.028 | 0.143 | 0.057 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.057 0.042 DBMET01199 | DBMET01199 | |
| 0.038 | 0.154 | 0.139 | Androgen antagonist | 0.139 0.026 DBMET01199 | DBMET01199 | |
| 0.042 | 0.16 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DBMET01199 | DBMET01199 | |
| 0.087 | 0.206 | 0.119 | Vanilloid 1 agonist | 0.119 0.089 DBMET01199 | DBMET01199 | |
| 0.028 | 0.148 | 0.098 | Sphingosine 1-phosphate receptor 4 agonist | 0.098 0.026 DBMET01199 | DBMET01199 | |
| 0.009 | 0.128 | 0.052 | Sirtuin 2 inhibitor | 0.052 0.012 DBMET01199 | DBMET01199 | |
| 0.045 | 0.165 | 0.097 | Keratolytic | 0.097 0.032 DBMET01199 | DBMET01199 | |
| 0.022 | 0.143 | 0.061 | Prolyl endopeptidase inhibitor | 0.061 0.024 DBMET01199 | DBMET01199 | |
| 0.024 | 0.146 | 0.1 | Biliverdin reductase inhibitor | 0.1 0.019 DBMET01199 | DBMET01199 | |
| 0.01 | 0.133 | 0.047 | Diamine oxidase inhibitor | 0.047 0.017 DBMET01199 | DBMET01199 | |
| 0.049 | 0.172 | 0.142 | MAO inhibitor | 0.142 0.064 DBMET01199 | DBMET01199 | |
| 0.025 | 0.153 | 0.067 | Glucose-6-phosphate isomerase inhibitor | 0.067 0.014 DBMET01199 | DBMET01199 | |
| 0.103 | 0.231 | 0.236 | Neurotrophic factor enhancer | 0.149 0.139 DBMET01198 0.236 0.047 DBMET01199 | DBMET01199 | |
| 0.028 | 0.156 | 0.061 | Heparanase inhibitor | 0.061 0.022 DBMET01199 | DBMET01199 | |
| 0.089 | 0.219 | 0.142 | Adenylate cyclase stimulant | 0.142 0.077 DBMET01199 | DBMET01199 | |
| 0.057 | 0.188 | 0.131 | AMP-activated protein kinase stimulant | 0.09 0.085 DBMET01197 0.131 0.041 DBMET01199 | DBMET01199 | |
| 0.085 | 0.218 | 0.171 | Sphingosine 1-phosphate receptor 2 antagonist | 0.124 0.088 DBMET01197 0.171 0.02 DBMET01199 | DBMET01199 | |
| 0.01 | 0.143 | 0.038 | Fumarate hydratase inhibitor | 0.038 0.02 DBMET01199 | DBMET01199 | |
| 0.083 | 0.216 | 0.205 | Anesthetic general | 0.205 0.072 DBMET01199 | DBMET01199 | |
| 0.007 | 0.14 | 0.051 | Uridine phosphorylase inhibitor | 0.051 0.008 DBMET01199 | DBMET01199 | |
| 0.02 | 0.155 | 0.052 | Glutamate (mGluR8) agonist | 0.052 0.01 DBMET01199 | DBMET01199 | |
| 0.013 | 0.15 | 0.055 | Guanylate cyclase inhibitor | 0.055 0.017 DBMET01199 | DBMET01199 | |
| 0.01 | 0.149 | 0.04 | TRPM8 blocker | 0.04 0.025 DBMET01199 | DBMET01199 | |
| 0.03 | 0.17 | 0.118 | Glutamate decarboxylase inhibitor | 0.118 0.022 DBMET01199 | DBMET01199 | |
| 0.008 | 0.148 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 DBMET01197 | DBMET01197 | |
| 0.019 | 0.159 | 0.076 | Acyl-CoA dehydrogenase inhibitor | 0.076 0.024 DBMET01199 | DBMET01199 | |
| 0.023 | 0.163 | 0.073 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.073 0.004 DBMET01199 | DBMET01199 | |
| 0.095 | 0.236 | 0.27 | 3C-like protease (Human coronavirus) inhibitor | 0.27 0.019 DBMET01199 | DBMET01199 | |
| 0.065 | 0.206 | 0.108 | TRPA1 agonist | 0.108 0.074 DBMET01199 | DBMET01199 | |
| 0.045 | 0.187 | 0.215 | HIV-1 integrase (Overall Integration) inhibitor | 0.215 0.009 DBMET01199 | DBMET01199 | |
| 0.048 | 0.19 | 0.086 | Breast cancer-resistant protein inhibitor | 0.086 0.072 DBMET01199 | DBMET01199 | |
| 0.017 | 0.16 | 0.089 | 5 Hydroxytryptamine 2 agonist | 0.089 0.012 DBMET01197 0.057 0.03 DBMET01199 | DBMET01197 | |
| 0.019 | 0.162 | 0.054 | Poly(ADP-ribose) polymerase inhibitor | 0.054 0.02 DBMET01197 | DBMET01197 | |
| 0.007 | 0.15 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.013 DBMET01197 0.034 0.013 DBMET01199 | DBMET01199 | |
| 0.032 | 0.176 | 0.094 | Acetylcholine nicotinic antagonist | 0.094 0.043 DBMET01197 | DBMET01197 | |
| 0.028 | 0.172 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.038 DBMET01199 | DBMET01199 | |
| 0.008 | 0.152 | 0.036 | Retinoid X receptor agonist | 0.036 0.025 DBMET01199 | DBMET01199 | |
| 0.018 | 0.163 | 0.065 | Dihydroorotase inhibitor | 0.065 0.014 DBMET01199 | DBMET01199 | |
| 0.018 | 0.163 | 0.037 | Protein kinase C beta I inhibitor | 0.033 0.024 DBMET01197 0.037 0.014 DBMET01199 | DBMET01199 | |
| 0.064 | 0.209 | 0.264 | NADPH oxidase inhibitor | 0.264 0.018 DBMET01197 0.247 0.021 DBMET01199 | DBMET01197 | |
| 0.009 | 0.155 | 0.052 | Free fatty acid receptor 1 antagonist | 0.052 0.008 DBMET01199 | DBMET01199 | |
| 0.016 | 0.163 | 0.067 | Aldose reductase inhibitor | 0.067 0.029 DBMET01199 | DBMET01199 | |
| 0.036 | 0.185 | 0.059 | Beta 3 adrenoreceptor antagonist | 0.059 0.058 DBMET01199 | DBMET01199 | |
| 0.012 | 0.163 | 0.105 | Cannabinoid CB2 receptor antagonist | 0.105 0.014 DBMET01199 | DBMET01199 | |
| 0.035 | 0.186 | 0.08 | Acetylcholine nicotinic agonist | 0.08 0.057 DBMET01197 | DBMET01197 | |
| 0.006 | 0.158 | 0.013 | Cyclin D2 inhibitor | 0.013 0.009 DBMET01197 0.013 0.009 DBMET01199 | DBMET01199 | |
| 0.035 | 0.187 | 0.107 | Glutamate (mGluR7) antagonist | 0.107 0.007 DBMET01199 | DBMET01199 | |
| 0.111 | 0.263 | 0.284 | Histone acetyltransferase inhibitor | 0.284 0.017 DBMET01199 | DBMET01199 | |
| 0.025 | 0.178 | 0.07 | Carbonic anhydrase stimulant | 0.07 0.031 DBMET01197 0.07 0.031 DBMET01199 | DBMET01199 | |
| 0.011 | 0.164 | 0.055 | Peroxisome proliferator-activated receptor alpha agonist | 0.055 0.029 DBMET01199 | DBMET01199 | |
| 0.01 | 0.164 | 0.031 | Retinoid X gamma receptor antagonist | 0.031 0.011 DBMET01199 | DBMET01199 | |
| 0.01 | 0.165 | 0.038 | Catechol O-methyltransferase inhibitor | 0.038 0.016 DBMET01199 | DBMET01199 | |
| 0.022 | 0.179 | 0.056 | Protein kinase C eta inhibitor | 0.056 0.037 DBMET01199 | DBMET01199 | |
| 0.049 | 0.206 | 0.128 | NADH dehydrogenase inhibitor | 0.128 0.024 DBMET01199 | DBMET01199 | |
| 0.041 | 0.198 | 0.081 | Orexin receptor 1 antagonist | 0.081 0.033 DBMET01199 | DBMET01199 | |
| 0.033 | 0.191 | 0.147 | Monophenol monooxygenase inhibitor | 0.147 0.048 DBMET01199 | DBMET01199 | |
| 0.011 | 0.171 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.028 DBMET01199 | DBMET01199 | |
| 0.027 | 0.187 | 0.054 | Sphingosine kinase inhibitor | 0.054 0.05 DBMET01199 | DBMET01199 | |
| 0.024 | 0.184 | 0.053 | Histamine H4 receptor antagonist | 0.053 0.026 DBMET01197 | DBMET01197 | |
| 0.039 | 0.202 | 0.07 | Phosphodiesterase VI inhibitor | 0.07 0.062 DBMET01199 | DBMET01199 | |
| 0.021 | 0.185 | 0.049 | Vanilloid 3 antagonist | 0.049 0.009 DBMET01199 | DBMET01199 | |
| 0.011 | 0.175 | 0.061 | Integrin alpha2beta1 antagonist | 0.061 0.004 DBMET01199 | DBMET01199 | |
| 0.054 | 0.219 | 0.119 | D-Ala-D-Ala ligase inhibitor | 0.119 0.014 DBMET01199 | DBMET01199 | |
| 0.01 | 0.178 | 0.036 | Retinoid X alpha receptor agonist | 0.036 0.023 DBMET01199 | DBMET01199 | |
| 0.029 | 0.197 | 0.084 | Aminopeptidase I inhibitor | 0.084 0.039 DBMET01199 | DBMET01199 | |
| 0.018 | 0.186 | 0.065 | Potassium channel (Inward rectifier) blocker | 0.065 0.02 DBMET01199 | DBMET01199 | |
| 0.004 | 0.174 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.01 DBMET01197 | DBMET01197 | |
| 0.039 | 0.209 | 0.088 | Glutamate (mGluR6) antagonist | 0.088 0.017 DBMET01199 | DBMET01199 | |
| 0.131 | 0.301 | 0.339 | Insulysin inhibitor | 0.339 0.038 DBMET01199 | DBMET01199 | |
| 0.078 | 0.248 | 0.135 | Nitric oxide antagonist | 0.135 0.112 DBMET01198 | DBMET01198 | |
| 0.018 | 0.188 | 0.063 | 5 Hydroxytryptamine 6 antagonist | 0.063 0.034 DBMET01197 | DBMET01197 | |
| 0.039 | 0.209 | 0.146 | Glycine receptor agonist | 0.146 0.007 DBMET01199 | DBMET01199 | |
| 0.035 | 0.205 | 0.094 | Glutamate dehydrogenase inhibitor | 0.094 0.034 DBMET01199 | DBMET01199 | |
| 0.059 | 0.23 | 0.221 | Adenylate kinase inhibitor | 0.221 0.012 DBMET01199 | DBMET01199 | |
| 0.048 | 0.22 | 0.116 | Thioredoxin inhibitor | 0.116 0.034 DBMET01199 | DBMET01199 | |
| 0.128 | 0.3 | 0.217 | DNA polymerase beta inhibitor | 0.217 0.212 DBMET01199 | DBMET01199 | |
| 0.014 | 0.188 | 0.031 | RNA-directed RNA polymerase inhibitor | 0.031 0.03 DBMET01199 | DBMET01199 | |
| 0.004 | 0.181 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 DBMET01197 | DBMET01197 | |
| 0.102 | 0.28 | 0.172 | Neurotensin receptor agonist | 0.172 0.059 DBMET01199 | DBMET01199 | |
| 0.021 | 0.2 | 0.177 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.177 0.004 DBMET01199 | DBMET01199 | |
| 0.017 | 0.197 | 0.037 | Acid-sensing ion channel blocker | 0.037 0.035 DBMET01197 | DBMET01197 | |
| 0.028 | 0.21 | 0.078 | Purinergic P2X1 antagonist | 0.078 0.026 DBMET01199 | DBMET01199 | |
| 0.042 | 0.224 | 0.184 | UDP-glucose 4-epimerase inhibitor | 0.184 0.02 DBMET01199 | DBMET01199 | |
| 0.024 | 0.207 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.091 0.04 DBMET01199 | DBMET01199 | |
| 0.012 | 0.195 | 0.037 | Oxytocin agonist | 0.037 0.035 DBMET01199 | DBMET01199 | |
| 0.015 | 0.202 | 0.03 | Hedgehog signaling activator | 0.03 0.012 DBMET01199 | DBMET01199 | |
| 0.047 | 0.234 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.038 DBMET01197 0.08 0.046 DBMET01199 | DBMET01197 | |
| 0.014 | 0.203 | 0.038 | NMDA receptor subunit 3B antagonist | 0.038 0.037 DBMET01199 | DBMET01199 | |
| 0.038 | 0.227 | 0.093 | Sphingomyelinase inhibitor | 0.093 0.069 DBMET01199 | DBMET01199 | |
| 0.009 | 0.199 | 0.071 | 5 Hydroxytryptamine 1F agonist | 0.071 0.004 DBMET01199 | DBMET01199 | |
| 0.014 | 0.205 | 0.197 | 5 Hydroxytryptamine agonist | 0.197 0.015 DBMET01197 | DBMET01197 | |
| 0.112 | 0.302 | 0.435 | Cholesterol antagonist | 0.435 0.043 DBMET01199 | DBMET01199 | |
| 0.006 | 0.197 | 0.033 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.017 DBMET01197 0.031 0.019 DBMET01199 | DBMET01197 | |
| 0.033 | 0.224 | 0.136 | Inducible nitric-oxide synthase inhibitor | 0.136 0.019 DBMET01199 | DBMET01199 | |
| 0.01 | 0.201 | 0.048 | Carbonic anhydrase VB inhibitor | 0.048 0.047 DBMET01199 | DBMET01199 | |
| 0.021 | 0.214 | 0.061 | Carbonic anhydrase VA inhibitor | 0.061 0.058 DBMET01199 | DBMET01199 | |
| 0.017 | 0.209 | 0.051 | Nicotinic neuronal receptor agonist | 0.051 0.045 DBMET01197 | DBMET01197 | |
| 0.044 | 0.238 | 0.143 | GABA C receptor antagonist | 0.126 0.046 DBMET01197 0.143 0.034 DBMET01199 | DBMET01199 | |
| 0.032 | 0.228 | 0.119 | Ornithine decarboxylase inhibitor | 0.119 0.027 DBMET01199 | DBMET01199 | |
| 0.052 | 0.248 | 0.171 | Psychostimulant | 0.171 0.099 DBMET01199 | DBMET01199 | |
| 0.014 | 0.21 | 0.053 | Histamine H2 receptor agonist | 0.053 0.019 DBMET01199 | DBMET01199 | |
| 0.004 | 0.201 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 DBMET01199 | DBMET01199 | |
| 0.029 | 0.227 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | 0.066 0.034 DBMET01197 0.069 0.03 DBMET01199 | DBMET01199 | |
| 0.042 | 0.24 | 0.135 | GABA receptor agonist | 0.106 0.07 DBMET01197 0.135 0.045 DBMET01199 | DBMET01199 | |
| 0.003 | 0.201 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | 0.015 0.006 DBMET01199 | DBMET01199 | |
| 0.007 | 0.207 | 0.051 | Carbonic anhydrase I inhibitor | 0.051 0.042 DBMET01199 | DBMET01199 | |
| 0.035 | 0.237 | 0.09 | Protein kinase C delta inhibitor | 0.09 0.062 DBMET01199 | DBMET01199 | |
| 0.025 | 0.227 | 0.096 | MAO A inhibitor | 0.096 0.067 DBMET01199 | DBMET01199 | |
| 0.017 | 0.221 | 0.076 | Alpha 2 adrenoreceptor agonist | 0.076 0.027 DBMET01197 | DBMET01197 | |
| 0.033 | 0.237 | 0.131 | Aminopeptidase B inhibitor | 0.131 0.047 DBMET01199 | DBMET01199 | |
| 0.035 | 0.239 | 0.122 | Carbonic anhydrase VI inhibitor | 0.122 0.029 DBMET01199 | DBMET01199 | |
| 0.014 | 0.219 | 0.074 | Integrin alpha2 antagonist | 0.035 0.03 DBMET01197 0.074 0.005 DBMET01199 | DBMET01199 | |
| 0.05 | 0.257 | 0.115 | Carbonic anhydrase XV inhibitor | 0.115 0.05 DBMET01199 | DBMET01199 | |
| 0.04 | 0.248 | 0.098 | Glutathione S-transferase inhibitor | 0.098 0.04 DBMET01199 | DBMET01199 | |
| 0.014 | 0.222 | 0.03 | Glucosylceramidase stimulant | 0.03 0.012 DBMET01199 | DBMET01199 | |
| 0.043 | 0.252 | 0.112 | GABA C receptor rho-1 antagonist | 0.1 0.062 DBMET01197 0.112 0.047 DBMET01199 | DBMET01199 | |
| 0.046 | 0.255 | 0.08 | mTOR complex 2 inhibitor | 0.08 0.07 DBMET01199 | DBMET01199 | |
| 0.053 | 0.263 | 0.227 | Photosensitizer | 0.227 0.008 DBMET01199 | DBMET01199 | |
| 0.005 | 0.215 | 0.08 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.08 0.004 DBMET01199 | DBMET01199 | |
| 0.014 | 0.225 | 0.083 | Glutamate (mGluR1a) antagonist | 0.083 0.008 DBMET01199 | DBMET01199 | |
| 0.009 | 0.221 | 0.04 | Peptide deformylase inhibitor | 0.04 0.014 DBMET01199 | DBMET01199 | |
| 0.016 | 0.23 | 0.052 | Nicotinic receptor alpha7 subunit antagonist | 0.052 0.04 DBMET01197 0.05 0.045 DBMET01199 | DBMET01197 | |
| 0.009 | 0.223 | 0.025 | Vanilloid 2 agonist | 0.025 0.018 DBMET01199 | DBMET01199 | |
| 0.042 | 0.257 | 0.139 | Estrogen receptor beta antagonist | 0.128 0.025 DBMET01198 0.139 0.019 DBMET01199 | DBMET01199 | |
| 0.073 | 0.289 | 0.238 | Antiamyloidogenic | 0.238 0.077 DBMET01199 | DBMET01199 | |
| 0.072 | 0.289 | 0.123 | DNA repair enzyme inhibitor | 0.107 0.104 DBMET01197 0.123 0.067 DBMET01199 | DBMET01199 | |
| 0.005 | 0.222 | 0.064 | Kynurenine 3 monooxygenase inhibitor | 0.064 0.005 DBMET01199 | DBMET01199 | |
| 0.006 | 0.224 | 0.034 | Peroxisome proliferator-activated receptor delta agonist | 0.034 0.023 DBMET01199 | DBMET01199 | |
| 0.016 | 0.234 | 0.046 | AICAR transformylase inhibitor | 0.046 0.028 DBMET01199 | DBMET01199 | |
| 0.057 | 0.276 | 0.254 | Interleukin 8 antagonist | 0.121 0.06 DBMET01197 0.254 0.005 DBMET01199 | DBMET01199 | |
| 0.032 | 0.253 | 0.102 | Urease inhibitor | 0.102 0.064 DBMET01199 | DBMET01199 | |
| 0.037 | 0.259 | 0.354 | Tubulin antagonist | 0.354 0.014 DBMET01199 | DBMET01199 | |
| 0.078 | 0.3 | 0.165 | CF transmembrane conductance regulator agonist | 0.165 0.053 DBMET01199 | DBMET01199 | |
| 0.015 | 0.238 | 0.067 | Cyclin-dependent kinase 6 inhibitor | 0.067 0.033 DBMET01197 | DBMET01197 | |
| 0.01 | 0.233 | 0.035 | Protein kinase C beta II inhibitor | 0.031 0.025 DBMET01197 0.035 0.017 DBMET01199 | DBMET01199 | |
| 0.015 | 0.239 | 0.103 | Phosphofructokinase-1 inhibitor | 0.103 0.031 DBMET01199 | DBMET01199 | |
| 0.034 | 0.258 | 0.098 | Caspase 7 inhibitor | 0.098 0.031 DBMET01199 | DBMET01199 | |
| 0.013 | 0.237 | 0.093 | Cannabinoid receptor agonist | 0.093 0.029 DBMET01199 | DBMET01199 | |
| 0.026 | 0.251 | 0.068 | Orexin receptor antagonist | 0.068 0.044 DBMET01199 | DBMET01199 | |
| 0.038 | 0.263 | 0.117 | Anabolic | 0.117 0.042 DBMET01199 | DBMET01199 | |
| 0.022 | 0.25 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.023 DBMET01199 | DBMET01199 | |
| 0.006 | 0.234 | 0.045 | Vascular adhesion protein 1 inhibitor | 0.045 0.019 DBMET01197 0.038 0.028 DBMET01199 | DBMET01197 | |
| 0.026 | 0.258 | 0.078 | CD45 antagonist | 0.078 0.013 DBMET01199 | DBMET01199 | |
| 0.019 | 0.252 | 0.136 | Porphobilinogen synthase inhibitor | 0.136 0.024 DBMET01199 | DBMET01199 | |
| 0.006 | 0.239 | 0.055 | Carbonic anhydrase II inhibitor | 0.055 0.039 DBMET01199 | DBMET01199 | |
| 0.019 | 0.254 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | 0.07 0.026 DBMET01199 | DBMET01199 | |
| 0.041 | 0.278 | 0.122 | Caspase 3 inhibitor | 0.122 0.057 DBMET01199 | DBMET01199 | |
| 0.013 | 0.25 | 0.056 | NMDA receptor glycine site agonist | 0.056 0.05 DBMET01199 | DBMET01199 | |
| 0.017 | 0.256 | 0.068 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.068 0.027 DBMET01199 | DBMET01199 | |
| 0.058 | 0.297 | 0.229 | Arachidonic acid antagonist | 0.229 0.012 DBMET01199 | DBMET01199 | |
| 0.002 | 0.244 | 0.019 | G-protein-coupled receptor 120 agonist | 0.019 0.01 DBMET01199 | DBMET01199 | |
| 0.022 | 0.265 | 0.054 | Topoisomerase II beta inhibitor | 0.054 0.028 DBMET01199 | DBMET01199 | |
| 0.024 | 0.269 | 0.096 | Dihydroorotate oxidase inhibitor | 0.096 0.005 DBMET01199 | DBMET01199 | |
| 0.004 | 0.251 | 0.033 | Orexin receptor 2 antagonist | 0.033 0.028 DBMET01199 | DBMET01199 | |
| 0.017 | 0.264 | 0.057 | Androgen agonist | 0.057 0.045 DBMET01199 | DBMET01199 | |
| 0.006 | 0.253 | 0.057 | Geranyltranstransferase inhibitor | 0.057 0.016 DBMET01199 | DBMET01199 | |
| 0.103 | 0.351 | 0.249 | RNA-directed DNA polymerase inhibitor | 0.249 0.05 DBMET01199 | DBMET01199 | |
| 0.017 | 0.264 | 0.069 | HIV-1 reverse transcriptase inhibitor | 0.069 0.05 DBMET01199 | DBMET01199 | |
| 0.061 | 0.309 | 0.131 | DNA methyltransferase I inhibitor | 0.131 0.128 DBMET01199 | DBMET01199 | |
| 0.044 | 0.294 | 0.369 | Cyclooxygenase inhibitor | 0.369 0.009 DBMET01199 | DBMET01199 | |
| 0.016 | 0.268 | 0.039 | Glutamate (mGluR group III) agonist | 0.039 0.035 DBMET01199 | DBMET01199 | |
| 0.015 | 0.267 | 0.074 | Amidase inhibitor | 0.074 0.043 DBMET01199 | DBMET01199 | |
| 0.01 | 0.262 | 0.054 | Glutamate (mGluR3) antagonist | 0.054 0.011 DBMET01199 | DBMET01199 | |
| 0.071 | 0.324 | 0.144 | MAP kinase 3 inhibitor | 0.144 0.077 DBMET01199 | DBMET01199 | |
| 0.065 | 0.318 | 0.166 | GABA C receptor rho-2 antagonist | 0.166 0.055 DBMET01199 | DBMET01199 | |
| 0.013 | 0.267 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.017 DBMET01199 | DBMET01199 | |
| 0.021 | 0.277 | 0.075 | Epoxide hydrolase inhibitor | 0.075 0.047 DBMET01199 | DBMET01199 | |
| 0.04 | 0.297 | 0.124 | Electrolyte absorption antagonist | 0.124 0.033 DBMET01199 | DBMET01199 | |
| 0.004 | 0.261 | 0.05 | Progesterone antagonist | 0.05 0.018 DBMET01199 | DBMET01199 | |
| 0.04 | 0.298 | 0.09 | Carbonic anhydrase III inhibitor | 0.09 0.075 DBMET01199 | DBMET01199 | |
| 0.012 | 0.27 | 0.07 | Argininosuccinate synthase inhibitor | 0.07 0.03 DBMET01199 | DBMET01199 | |
| 0.032 | 0.292 | 0.118 | Nitric-oxide synthase inhibitor | 0.118 0.039 DBMET01199 | DBMET01199 | |
| 0.018 | 0.279 | 0.088 | Nav1.7 sodium channel blocker | 0.079 0.035 DBMET01197 0.088 0.028 DBMET01199 | DBMET01199 | |
| 0.012 | 0.273 | 0.1 | Alcohol oxidase inhibitor | 0.1 0.018 DBMET01199 | DBMET01199 | |
| 0.048 | 0.31 | 0.094 | Estrogen-related receptor beta agonist | 0.094 0.033 DBMET01199 | DBMET01199 | |
| 0.005 | 0.266 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 DBMET01199 | DBMET01199 | |
| 0.005 | 0.267 | 0.029 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.029 0.019 DBMET01199 | DBMET01199 | |
| 0.023 | 0.286 | 0.127 | MAP kinase kinase kinase inhibitor | 0.127 0.047 DBMET01199 | DBMET01199 | |
| 0.013 | 0.276 | 0.048 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.039 DBMET01199 | DBMET01199 | |
| 0.006 | 0.269 | 0.04 | Motilin receptor agonist | 0.04 0.007 DBMET01197 | DBMET01197 | |
| 0.025 | 0.289 | 0.241 | Alcohol dehydrogenase inhibitor | 0.241 0.008 DBMET01199 | DBMET01199 | |
| 0.03 | 0.295 | 0.099 | Gastric antisecretory | 0.099 0.067 DBMET01199 | DBMET01199 | |
| 0.006 | 0.272 | 0.042 | Estrogen agonist | 0.042 0.041 DBMET01198 | DBMET01198 | |
| 0.036 | 0.303 | 0.114 | Alkaline phosphatase inhibitor | 0.114 0.094 DBMET01199 | DBMET01199 | |
| 0.006 | 0.273 | 0.06 | Carbonic anhydrase inhibitor | 0.06 0.046 DBMET01199 | DBMET01199 | |
| 0.002 | 0.27 | 0.021 | Peroxisome proliferator-activated receptor alpha antagonist | 0.021 0.015 DBMET01199 | DBMET01199 | |
| 0.082 | 0.35 | 0.359 | MAP kinase kinase 4 inhibitor | 0.359 0.003 DBMET01199 | DBMET01199 | |
| 0.025 | 0.296 | 0.094 | Histamine N-methyltransferase inhibitor | 0.094 0.052 DBMET01199 | DBMET01199 | |
| 0.017 | 0.289 | 0.069 | Histidine decarboxylase inhibitor | 0.069 0.051 DBMET01199 | DBMET01199 | |
| 0.012 | 0.286 | 0.032 | Melatonin receptor 1A agonist | 0.032 0.026 DBMET01199 | DBMET01199 | |
| 0.025 | 0.3 | 0.055 | Ca(v)3.2 blocker | 0.055 0.051 DBMET01197 | DBMET01197 | |
| 0.037 | 0.312 | 0.339 | MAP kinase 13 inhibitor | 0.097 0.086 DBMET01197 0.339 0.005 DBMET01199 | DBMET01199 | |
| 0.005 | 0.281 | 0.146 | Beta tubulin antagonist | 0.146 0.013 DBMET01199 | DBMET01199 | |
| 0.058 | 0.334 | 0.577 | Aldehyde oxidase inhibitor | 0.577 0.022 DBMET01199 | DBMET01199 | |
| 0.013 | 0.29 | 0.132 | Benzodiazepine agonist | 0.132 0.012 DBMET01199 | DBMET01199 | |
| 0.02 | 0.297 | 0.103 | Potassium channel (ATP-sensitive) blocker | 0.103 0.014 DBMET01199 | DBMET01199 | |
| 0.006 | 0.284 | 0.054 | Liver X receptor beta antagonist | 0.054 0.007 DBMET01199 | DBMET01199 | |
| 0.029 | 0.308 | 0.089 | Peroxisome proliferator-activated receptor gamma antagonist | 0.089 0.024 DBMET01199 | DBMET01199 | |
| 0.018 | 0.298 | 0.081 | Cyclin D1 inhibitor | 0.081 0.017 DBMET01199 | DBMET01199 | |
| 0.009 | 0.29 | 0.056 | Cathepsin L inhibitor | 0.056 0.043 DBMET01199 | DBMET01199 | |
| 0.038 | 0.322 | 0.185 | Beta amyloid protein antagonist | 0.185 0.022 DBMET01199 | DBMET01199 | |
| 0.008 | 0.294 | 0.034 | Calcium release-activated channel blocker | 0.034 0.022 DBMET01199 | DBMET01199 | |
| 0.006 | 0.293 | 0.068 | Liver X receptor beta agonist | 0.068 0.007 DBMET01199 | DBMET01199 | |
| 0.086 | 0.374 | 0.26 | Gastrin inhibitor | 0.26 0.067 DBMET01199 | DBMET01199 | |
| 0.012 | 0.301 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.031 DBMET01199 | DBMET01199 | |
| 0.004 | 0.293 | 0.038 | Cathepsin L1 inhibitor | 0.038 0.029 DBMET01199 | DBMET01199 | |
| 0.057 | 0.348 | 0.135 | DNA methylase inhibitor | 0.135 0.132 DBMET01199 | DBMET01199 | |
| 0.074 | 0.366 | 0.342 | Calpain 2 inhibitor | 0.342 0.091 DBMET01199 | DBMET01199 | |
| 0.054 | 0.347 | 0.247 | Hexokinase inhibitor | 0.247 0.018 DBMET01199 | DBMET01199 | |
| 0.025 | 0.318 | 0.167 | Potassium channel activator | 0.167 0.015 DBMET01199 | DBMET01199 | |
| 0.028 | 0.321 | 0.072 | Sphingosine 1-phosphate receptor antagonist | 0.072 0.066 DBMET01199 | DBMET01199 | |
| 0.006 | 0.3 | 0.214 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.214 0.003 DBMET01199 | DBMET01199 | |
| 0.009 | 0.303 | 0.088 | Stearoyl-CoA desaturase inhibitor | 0.088 0.009 DBMET01199 | DBMET01199 | |
| 0.029 | 0.324 | 0.181 | MAP kinase kinase inhibitor | 0.181 0.036 DBMET01199 | DBMET01199 | |
| 0.031 | 0.326 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.033 DBMET01199 | DBMET01199 | |
| 0.01 | 0.308 | 0.04 | Sphingosine 1-phosphate receptor agonist | 0.04 0.038 DBMET01199 | DBMET01199 | |
| 0.019 | 0.319 | 0.076 | Fatty acid synthase inhibitor | 0.076 0.021 DBMET01199 | DBMET01199 | |
| 0.049 | 0.352 | 0.124 | Cyclin-dependent kinase 8 inhibitor | 0.124 0.112 DBMET01199 | DBMET01199 | |
| 0.04 | 0.345 | 0.085 | ABCA1 expression enhancer | 0.085 0.075 DBMET01199 | DBMET01199 | |
| 0.013 | 0.319 | 0.065 | Cholesterol esterase inhibitor | 0.065 0.013 DBMET01199 | DBMET01199 | |
| 0.057 | 0.367 | 0.219 | Calpain inhibitor | 0.219 0.095 DBMET01199 | DBMET01199 | |
| 0.017 | 0.328 | 0.123 | CYP2A6 inhibitor | 0.123 0.025 DBMET01199 | DBMET01199 | |
| 0.045 | 0.357 | 0.275 | MAP kinase kinase 2 inhibitor | 0.184 0.092 DBMET01197 0.275 0.044 DBMET01199 | DBMET01199 | |
| 0.016 | 0.331 | 0.097 | Potassium channel (ATP-sensitive) activator | 0.097 0.004 DBMET01199 | DBMET01199 | |
| 0.131 | 0.449 | 0.417 | 5 Hydroxytryptamine release inhibitor | 0.255 0.221 DBMET01197 0.417 0.068 DBMET01199 | DBMET01199 | |
| 0.019 | 0.338 | 0.095 | Transcription factor AP-1 inhibitor | 0.095 0.014 DBMET01199 | DBMET01199 | |
| 0.016 | 0.335 | 0.1 | Potassium channel (Inward rectifier) activator | 0.1 0.005 DBMET01199 | DBMET01199 | |
| 0.044 | 0.365 | 0.272 | Peroxidase inhibitor | 0.272 0.043 DBMET01199 | DBMET01199 | |
| 0.086 | 0.407 | 0.286 | Nootropic | 0.286 0.082 DBMET01197 | DBMET01197 | |
| 0.01 | 0.332 | 0.079 | Liver X receptor alpha agonist | 0.079 0.007 DBMET01199 | DBMET01199 | |
| 0.034 | 0.357 | 0.083 | Bromodomain-containing protein 2 inhibitor | 0.083 0.07 DBMET01199 | DBMET01199 | |
| 0.026 | 0.35 | 0.114 | Mucolytic | 0.114 0.061 DBMET01199 | DBMET01199 | |
| 0.022 | 0.346 | 0.05 | Sodium/calcium exchanger inhibitor | 0.05 0.035 DBMET01197 0.05 0.034 DBMET01199 | DBMET01199 | |
| 0.047 | 0.372 | 0.157 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.157 0.134 DBMET01199 | DBMET01199 | |
| 0.026 | 0.351 | 0.087 | GABA A receptor agonist | 0.087 0.052 DBMET01199 | DBMET01199 | |
| 0.004 | 0.33 | 0.038 | CXC chemokine 2 receptor antagonist | 0.038 0.009 DBMET01199 | DBMET01199 | |
| 0.01 | 0.337 | 0.105 | Glutamate receptor agonist | 0.105 0.034 DBMET01199 | DBMET01199 | |
| 0.019 | 0.347 | 0.069 | Cathepsin G inhibitor | 0.069 0.055 DBMET01199 | DBMET01199 | |
| 0.032 | 0.359 | 0.334 | MAP kinase 12 inhibitor | 0.334 0.005 DBMET01199 | DBMET01199 | |
| 0.036 | 0.364 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.1 0.034 DBMET01199 | DBMET01199 | |
| 0.032 | 0.361 | 0.139 | Xanthine oxidase inhibitor | 0.139 0.039 DBMET01199 | DBMET01199 | |
| 0.015 | 0.348 | 0.048 | Purinergic P2X4 antagonist | 0.048 0.029 DBMET01197 0.048 0.027 DBMET01199 | DBMET01199 | |
| 0.009 | 0.343 | 0.092 | Peroxisome proliferator-activated receptor gamma agonist | 0.092 0.033 DBMET01199 | DBMET01199 | |
| 0.013 | 0.347 | 0.043 | GABA B receptor antagonist | 0.043 0.03 DBMET01199 | DBMET01199 | |
| 0.007 | 0.341 | 0.033 | Nicotinic acid receptor agonist | 0.033 0.029 DBMET01199 | DBMET01199 | |
| 0.011 | 0.347 | 0.046 | Benzodiazepine antagonist | 0.046 0.036 DBMET01199 | DBMET01199 | |
| 0.007 | 0.347 | 0.057 | Leukocyte elastase inhibitor | 0.057 0.019 DBMET01199 | DBMET01199 | |
| 0.04 | 0.383 | 0.117 | Cyclooxygenase 3 inhibitor | 0.117 0.08 DBMET01199 | DBMET01199 | |
| 0.004 | 0.347 | 0.02 | Prostaglandin D2 antagonist | 0.02 0.019 DBMET01199 | DBMET01199 | |
| 0.029 | 0.376 | 0.085 | GABA B receptor agonist | 0.085 0.033 DBMET01199 | DBMET01199 | |
| 0.021 | 0.369 | 0.121 | Potassium channel (Ca-activated) activator | 0.121 0.04 DBMET01199 | DBMET01199 | |
| 0.023 | 0.379 | 0.06 | Alpha 1b adrenoreceptor agonist | 0.06 0.02 DBMET01197 | DBMET01197 | |
| 0.016 | 0.373 | 0.075 | Aldosterone antagonist | 0.075 0.012 DBMET01199 | DBMET01199 | |
| 0.004 | 0.362 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.023 DBMET01199 | DBMET01199 | |
| 0.129 | 0.489 | 0.192 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.192 0.191 DBMET01197 | DBMET01197 | |
| 0.057 | 0.42 | 0.157 | Cyclic AMP phosphodiesterase inhibitor | 0.157 0.14 DBMET01199 | DBMET01199 | |
| 0.003 | 0.367 | 0.047 | Carbonic anhydrase IV inhibitor | 0.047 0.027 DBMET01199 | DBMET01199 | |
| 0.006 | 0.372 | 0.05 | Adenosine A1 receptor antagonist | 0.05 0.049 DBMET01199 | DBMET01199 | |
| 0.01 | 0.375 | 0.422 | MAP kinase 14 inhibitor | 0.422 0.004 DBMET01199 | DBMET01199 | |
| 0.016 | 0.383 | 0.055 | MAP kinase kinase 9 inhibitor | 0.055 0.039 DBMET01199 | DBMET01199 | |
| 0.029 | 0.396 | 0.089 | DNA directed RNA polymerase inhibitor | 0.089 0.071 DBMET01199 | DBMET01199 | |
| 0.015 | 0.387 | 0.087 | Pim-3 kinase inhibitor | 0.087 0.062 DBMET01197 | DBMET01197 | |
| 0.101 | 0.475 | 0.413 | Interleukin 2 agonist | 0.413 0.024 DBMET01199 | DBMET01199 | |
| 0.004 | 0.385 | 0.039 | Glutamate (mGluR group II) antagonist | 0.039 0.025 DBMET01199 | DBMET01199 | |
| 0.004 | 0.386 | 0.023 | CC chemokine 9 receptor antagonist | 0.023 0.005 DBMET01199 | DBMET01199 | |
| 0.017 | 0.399 | 0.127 | Elastase 1 inhibitor | 0.127 0.01 DBMET01199 | DBMET01199 | |
| 0.021 | 0.405 | 0.121 | TRKA antagonist | 0.121 0.067 DBMET01199 | DBMET01199 | |
| 0.04 | 0.425 | 0.181 | Prostaglandin dehydrogenase inhibitor | 0.181 0.172 DBMET01199 | DBMET01199 | |
| 0.028 | 0.415 | 0.112 | Bile acid receptor antagonist | 0.112 0.029 DBMET01199 | DBMET01199 | |
| 0.008 | 0.395 | 0.053 | Dihydroorotate dehydrogenase inhibitor | 0.053 0.034 DBMET01199 | DBMET01199 | |
| 0.029 | 0.422 | 0.164 | I kappa B kinase epsilon inhibitor | 0.164 0.105 DBMET01199 | DBMET01199 | |
| 0.024 | 0.425 | 0.313 | Aryl hydrocarbon receptor agonist | 0.313 0.057 DBMET01199 | DBMET01199 | |
| 0.049 | 0.46 | 0.227 | Thyroid hormone beta antagonist | 0.227 0.134 DBMET01199 | DBMET01199 | |
| 0.009 | 0.422 | 0.046 | Mineralocorticoid receptor antagonist | 0.046 0.037 DBMET01199 | DBMET01199 | |
| 0.01 | 0.424 | 0.056 | MAP3K5 inhibitor | 0.056 0.008 DBMET01199 | DBMET01199 | |
| 0.011 | 0.426 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.025 DBMET01197 | DBMET01197 | |
| 0.01 | 0.427 | 0.085 | CDC25B inhibitor | 0.085 0.024 DBMET01199 | DBMET01199 | |
| 0.02 | 0.44 | 0.104 | Protein kinase C gamma inhibitor | 0.104 0.07 DBMET01199 | DBMET01199 | |
| 0.034 | 0.456 | 0.379 | Interleukin antagonist | 0.379 0.034 DBMET01199 | DBMET01199 | |
| 0.019 | 0.446 | 0.145 | Tyrosine-protein kinase receptor antagonist | 0.145 0.067 DBMET01199 | DBMET01199 | |
| 0.038 | 0.473 | 0.155 | Hemostatic | 0.155 0.062 DBMET01199 | DBMET01199 | |
| 0.061 | 0.497 | 0.195 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.195 0.077 DBMET01199 | DBMET01199 | |
| 0.006 | 0.442 | 0.093 | Prostaglandin-E synthase inhibitor | 0.093 0.031 DBMET01199 | DBMET01199 | |
| 0.02 | 0.459 | 0.089 | Interleukin 1 beta converting enzyme inhibitor | 0.089 0.074 DBMET01199 | DBMET01199 | |
| 0.044 | 0.483 | 0.229 | Thyroid hormone antagonist | 0.229 0.137 DBMET01199 | DBMET01199 | |
| 0.019 | 0.461 | 0.122 | Diuretic | 0.122 0.103 DBMET01199 | DBMET01199 | |
| 0.019 | 0.464 | 0.256 | Cyclooxygenase 2 inhibitor | 0.256 0.019 DBMET01199 | DBMET01199 | |
| 0.004 | 0.45 | 0.153 | 5 Hydroxytryptamine 2C agonist | 0.153 0.005 DBMET01197 | DBMET01197 | |
| 0.003 | 0.451 | 0.075 | Urate transporter 1 inhibitor | 0.075 0.009 DBMET01199 | DBMET01199 | |
| 0.012 | 0.46 | 0.35 | MAP kinase 11 inhibitor | 0.35 0.004 DBMET01199 | DBMET01199 | |
| 0.081 | 0.529 | 0.272 | Cyclophilin D inhibitor | 0.272 0.189 DBMET01199 | DBMET01199 | |
| 0.095 | 0.543 | 0.461 | Antiinflammatory | 0.461 0.105 DBMET01199 | DBMET01199 | |
| 0.031 | 0.484 | 0.408 | Antimitotic | 0.408 0.022 DBMET01199 | DBMET01199 | |
| 0.015 | 0.472 | 0.16 | LIM domain kinase 1 inhibitor | 0.16 0.089 DBMET01199 | DBMET01199 | |
| 0.004 | 0.46 | 0.061 | Cannabinoid CB2 receptor agonist | 0.061 0.034 DBMET01199 | DBMET01199 | |
| 0.015 | 0.475 | 0.16 | Autotaxin inhibitor | 0.16 0.007 DBMET01199 | DBMET01199 | |
| 0.005 | 0.47 | 0.049 | Nicotinic receptor alpha4 subunit antagonist | 0.049 0.034 DBMET01197 | DBMET01197 | |
| 0.005 | 0.474 | 0.026 | Thyroid hormone agonist | 0.026 0.018 DBMET01199 | DBMET01199 | |
| 0.006 | 0.475 | 0.132 | Protein kinase (CK1) delta inhibitor | 0.132 0.064 DBMET01199 | DBMET01199 | |
| 0.003 | 0.475 | 0.036 | Cyclin E2 inhibitor | 0.036 0.015 DBMET01199 | DBMET01199 | |
| 0.001 | 0.473 | 0.011 | Insulin like growth factor 3 antagonist | 0.011 0.003 DBMET01199 | DBMET01199 | |
| 0.008 | 0.482 | 0.057 | Diacylglycerol O-acyltransferase inhibitor | 0.057 0.028 DBMET01199 | DBMET01199 | |
| 0.029 | 0.505 | 0.105 | MAP kinase 7 inhibitor | 0.105 0.005 DBMET01199 | DBMET01199 | |
| 0.004 | 0.487 | 0.094 | Glutamate (mGluR1) antagonist | 0.094 0.018 DBMET01199 | DBMET01199 | |
| 0.007 | 0.505 | 0.068 | CDK4/cyclin D inhibitor | 0.068 0.029 DBMET01199 | DBMET01199 | |
| 0.006 | 0.507 | 0.052 | CDK4/cyclin D1 inhibitor | 0.052 0.047 DBMET01199 | DBMET01199 | |
| 0.036 | 0.561 | 0.102 | Interleukin 12 antagonist | 0.102 0.051 DBMET01199 | DBMET01199 | |
| 0.009 | 0.546 | 0.678 | p38 MAP kinase inhibitor | 0.678 0.004 DBMET01199 | DBMET01199 | |
| 0.009 | 0.553 | 0.097 | CDC25A inhibitor | 0.097 0.029 DBMET01199 | DBMET01199 | |
| 0.004 | 0.561 | 0.05 | Kinesin antagonist | 0.05 0.016 DBMET01199 | DBMET01199 | |
| 0.004 | 0.561 | 0.05 | Kinesin-like protein 1 inhibitor | 0.05 0.016 DBMET01199 | DBMET01199 | |
| 0.016 | 0.574 | 0.201 | TRKC antagonist | 0.201 0.067 DBMET01199 | DBMET01199 | |
| 0.006 | 0.567 | 0.177 | Alpha tubulin antagonist | 0.177 0.007 DBMET01199 | DBMET01199 | |
| 0.004 | 0.57 | 0.056 | GABA A receptor antagonist | 0.056 0.034 DBMET01199 | DBMET01199 | |
| 0.014 | 0.582 | 0.063 | CXC chemokine 1 receptor antagonist | 0.063 0.018 DBMET01199 | DBMET01199 | |
| 0.004 | 0.576 | 0.058 | GABA receptor antagonist | 0.058 0.033 DBMET01199 | DBMET01199 | |
| 0.012 | 0.594 | 0.085 | Potassium channel (Ca-activated) blocker | 0.085 0.015 DBMET01199 | DBMET01199 | |
| 0.01 | 0.599 | 0.157 | TRKB antagonist | 0.157 0.043 DBMET01199 | DBMET01199 | |
| 0.005 | 0.615 | 0.06 | Glutamate (mGluR) agonist | 0.06 0.045 DBMET01199 | DBMET01199 | |
| 0.01 | 0.627 | 0.093 | Nav1.8 sodium channel blocker | 0.093 0.032 DBMET01199 | DBMET01199 | |
| 0.008 | 0.633 | 0.124 | Stem cell growth factor agonist | 0.124 0.029 DBMET01199 | DBMET01199 | |
| 0.003 | 0.657 | 0.04 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.04 0.002 DBMET01199 | DBMET01199 | |
| 0.012 | 0.669 | 0.203 | Dual specificity phosphatase 3 inhibitor | 0.203 0.059 DBMET01199 | DBMET01199 | |
| 0.016 | 0.689 | 0.238 | Interleukin 6 antagonist | 0.238 0.026 DBMET01199 | DBMET01199 | |
| 0.008 | 0.689 | 0.105 | Platelet growth factor antagonist | 0.105 0.038 DBMET01199 | DBMET01199 | |
| 0.009 | 0.711 | 0.207 | Uric acid excretion stimulant | 0.207 0.012 DBMET01199 | DBMET01199 | |
| 0.041 | 0.747 | 0.174 | Lipocortins synthesis antagonist | 0.174 0.077 DBMET01199 | DBMET01199 | |
| 0.004 | 0.718 | 0.057 | Raf kinase B inhibitor | 0.057 0.043 DBMET01199 | DBMET01199 | |
| 0.004 | 0.726 | 0.027 | Liver X receptor alpha antagonist | 0.027 0.024 DBMET01199 | DBMET01199 | |
| 0.017 | 0.742 | 0.191 | Angiogenesis inhibitor | 0.191 0.181 DBMET01199 | DBMET01199 | |
| 0.011 | 0.736 | 0.166 | Dual specificity phosphatase inhibitor | 0.166 0.079 DBMET01199 | DBMET01199 | |
| 0.014 | 0.745 | 0.271 | Farnesoid X receptor antagonist | 0.271 0.009 DBMET01199 | DBMET01199 | |
| 0.004 | 0.755 | 0.049 | Liver X receptor agonist | 0.049 0.024 DBMET01199 | DBMET01199 | |
| 0.004 | 0.755 | 0.03 | Glucocorticoid antagonist | 0.03 0.024 DBMET01199 | DBMET01199 | |
| 0.004 | 0.758 | 0.071 | Raf kinase inhibitor | 0.071 0.053 DBMET01199 | DBMET01199 | |
| 0.004 | 0.758 | 0.045 | Neuropeptide Y5 antagonist | 0.045 0.042 DBMET01199 | DBMET01199 | |
| 0.004 | 0.758 | 0.043 | Peroxisome proliferator-activated receptor delta antagonist | 0.043 0.012 DBMET01199 | DBMET01199 | |
| 0.004 | 0.759 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | 0.021 0.007 DBMET01199 | DBMET01199 | |
| 0.007 | 0.778 | 0.063 | Elastase 3B inhibitor | 0.063 0.003 DBMET01199 | DBMET01199 | |
| 0.007 | 0.778 | 0.063 | Elastase 2B inhibitor | 0.063 0.003 DBMET01199 | DBMET01199 | |
| 0.007 | 0.778 | 0.063 | Elastase 3A inhibitor | 0.063 0.003 DBMET01199 | DBMET01199 | |
| 0.004 | 0.785 | 0.08 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.08 0.072 DBMET01199 | DBMET01199 | |
| 0.004 | 0.805 | 0.112 | Check point kinase 2 inhibitor | 0.112 0.055 DBMET01199 | DBMET01199 | |
| 0.003 | 0.806 | 0.059 | CDK2/cyclin E inhibitor | 0.059 0.043 DBMET01199 | DBMET01199 | |
| 0.023 | 0.862 | 0.255 | Growth factor agonist | 0.255 0.029 DBMET01199 | DBMET01199 | |
| 0.003 | 0.855 | 0.196 | Raf kinase C inhibitor | 0.196 0.01 DBMET01199 | DBMET01199 | |
| 0.055 | 0.908 | 0.614 | Calcium channel L-type activator | 0.614 0.005 DBMET01199 | DBMET01199 | |
| 0.008 | 0.89 | 0.054 | Alpha 1L adrenoreceptor agonist | 0.054 0.013 DBMET01197 | DBMET01197 | |
| 0.004 | 0.897 | 0.063 | Cyclin B2 inhibitor | 0.063 0.029 DBMET01199 | DBMET01199 | |
| 0.003 | 0.898 | 0.056 | CDK1/cyclin B inhibitor | 0.056 0.051 DBMET01199 | DBMET01199 | |
| 0.003 | 0.909 | 0.051 | Cyclin B inhibitor | 0.051 0.045 DBMET01199 | DBMET01199 | |
| 0.004 | 0.921 | 0.063 | Cyclin B1 inhibitor | 0.063 0.04 DBMET01199 | DBMET01199 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |